Data / Research funding / Digestive Diseases
Digestive Diseases: 9,233 NIH awards ($11.2B) to 910 organizations
9,233 NIH awards ($11.2B) in the NIH spending category Digestive Diseases, to 910 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 9,233 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $472,070,715 | December 1, 2024 | November 30, 2025 | CURRIER, JUDITH S. | reporter.nih.gov |
| AIDS Clinical Trial Group Laboratory Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $56,714,107 | January 1, 2014 | November 30, 2027 | ALDROVANDI, GRACE M | reporter.nih.gov |
| Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $44,959,734 | August 13, 2025 | November 30, 2026 | KOTLOFF, KAREN L. | reporter.nih.gov |
| Epidemiology of Diabetes Interventions and Complications (EDIC) Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $35,015,476 | September 22, 2011 | June 30, 2027 | GUBITOSI-KLUG, ROSE A | reporter.nih.gov |
| Mayo Clinic Comprehensive Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $29,249,641 | April 25, 1997 | August 31, 2030 | WILLMAN, CHERYL LYNN | reporter.nih.gov |
| New Horizons in the Prevention and Treatment of Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $25,961,502 | April 4, 2024 | February 28, 2031 | WOOD, ROBERT A | reporter.nih.gov |
| University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $24,477,809 | February 1, 2007 | November 30, 2027 | ERON, JOSEPH J | reporter.nih.gov |
| Environmental triggers of early-onset colorectal cancer: interactions between microplastics and pks+ E coli in early-life gut colonization | NIH | National Cancer Institute | 2021 to 2025 | $22,669,275 | August 1, 1997 | July 31, 2026 | TUVESON, DAVID A | reporter.nih.gov |
| Moffitt Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $22,007,955 | February 18, 1998 | January 31, 2027 | CLEVELAND, JOHN L. | reporter.nih.gov |
| UT Southwestern Medical Center Simmons Comprehensive Cancer Center | NIH | National Cancer Institute | 2021 to 2025 | $21,900,548 | September 1, 2010 | July 31, 2026 | ARTEAGA, CARLOS L | reporter.nih.gov |
| UCLA AIDS Prevention and Treatment Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,546,764 | February 1, 2007 | November 30, 2027 | LANDOVITZ, RAPHAEL J | reporter.nih.gov |
| Boston HIV CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,445,869 | January 15, 2007 | November 30, 2027 | KURITZKES, DANIEL R. | reporter.nih.gov |
| Vaccine and Treatment Evaluation Unit at Saint Louis University | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,219,564 | December 11, 2019 | November 30, 2026 | HOFT, DANIEL F. | reporter.nih.gov |
| University of Arizona Cancer Center - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $21,155,920 | July 1, 1997 | July 31, 2027 | THEODORESCU, DAN | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $19,528,719 | June 1, 1997 | June 30, 2028 | STEIDL, ULRICH | reporter.nih.gov |
| Expanding HOPE Liver Transplantation: Understanding Opportunistic Infection and Cancer Risk | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,807,472 | August 1, 2018 | August 31, 2030 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| NIAID VIROLOGY QUALITY ASSURANCE (VQA) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $17,732,468 | June 21, 2025 | June 20, 2026 | DENNY, THOMAS | reporter.nih.gov |
| Guide RNA manufacturing capabilities for platform in vivo base editing therapies for metabolic liver diseases | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $17,556,074 | August 1, 2023 | July 31, 2028 | PERANTEAU, WILLIAM H. | reporter.nih.gov |
| Data Coordinating Center for the Type 1 Diabetes in Acute Pancreatitis Consortium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $17,043,926 | September 17, 2020 | July 31, 2025 | CHINCHILLI, VERNON M | reporter.nih.gov |
| International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,840,939 | May 1, 2025 | April 30, 2027 | ROHNER, ELIANE | reporter.nih.gov |
| Biology of the Hormonal Regulation of Cancer and Immuno Oncology Outcomes Research Proposal. | NIH | National Cancer Institute | 2021 to 2025 | $15,746,743 | August 1, 1997 | June 30, 2027 | COUSSENS, LISA M | reporter.nih.gov |
| Pancreatitis-induced initiation of early onset pancreatic cancer | NIH | National Cancer Institute | 2021 to 2025 | $15,447,190 | February 1, 2025 | January 31, 2026 | SHAW, REUBEN | reporter.nih.gov |
| Center for Cellular Metabolism Research in Oklahoma | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $15,159,612 | February 5, 2021 | January 31, 2027 | XIA, LIJUN | reporter.nih.gov |
| Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $13,418,019 | June 15, 2021 | May 31, 2027 | ALONSO, ESTELLA M. | reporter.nih.gov |
| Pitt-Ohio State Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,065,770 | February 1, 2007 | November 30, 2027 | RIDDLER, SHARON | reporter.nih.gov |
| Hepatobiology and Toxicology COBRE | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $12,863,981 | June 10, 2016 | March 31, 2027 | MCCLAIN, CRAIG J. | reporter.nih.gov |
| Vanderbilt HIV Clinical Trials Unit (CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,733,650 | February 1, 2007 | November 30, 2027 | HAAS, DAVID W | reporter.nih.gov |
| Functional Microbiomics, Inflammation and Pathogenicity | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $12,492,994 | March 1, 2018 | February 29, 2028 | LAMONT, RICHARD J | reporter.nih.gov |
| CURE CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,461,433 | January 1, 2007 | November 30, 2027 | SPECTOR, STEPHEN A | reporter.nih.gov |
| AIDS Linked to the IntraVenous Experience (ALIVE) Study | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,226,379 | January 1, 2014 | May 31, 2030 | MEHTA, SHRUTI H | reporter.nih.gov |
| COBRE in Digestive and Liver Disease | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,909,573 | April 3, 2020 | June 30, 2030 | DUNCAN, STEPHEN A | reporter.nih.gov |
| Durable Alteration of the Human Immune system after Infection or Immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,785,761 | June 8, 2009 | May 31, 2029 | CHUNG, RAYMOND T | reporter.nih.gov |
| Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD) - Indiana University Data Coordinating Center | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $11,773,646 | August 1, 2018 | June 30, 2029 | TU, WANZHU | reporter.nih.gov |
| Center for Pre-Clinical Cancer Research | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,277,290 | March 1, 2021 | February 28, 2027 | FRANCIS, JOSEPH | reporter.nih.gov |
| A Follow-up Study for Causes of Cancer in Black Women | NIH | National Cancer Institute | 2021 to 2025 | $11,271,706 | September 21, 2012 | August 31, 2027 | PALMER, JULIE R | reporter.nih.gov |
| Mays Cancer Center at UT Health SA | NIH | National Cancer Institute | 2021 to 2025 | $11,193,809 | August 1, 1997 | July 31, 2026 | ZHENG, LEI | reporter.nih.gov |
| Administrative Supplement for the NCI P30 CCSG to extend partnerships with comprehensive cancer control coalitions to study implementation of evidence-based cancer control interventions | NIH | National Cancer Institute | 2021 | $11,079,774 | January 1, 1997 | March 31, 2022 | LYNCH, THOMAS JAMES | reporter.nih.gov |
| Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,920,671 | September 6, 2021 | June 30, 2028 | BOIKE, JUSTIN | reporter.nih.gov |
| Reagent Program for HIV and other Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $10,735,388 | October 15, 2023 | January 13, 2024 | RASHID, SUJATHA | reporter.nih.gov |
| Liver Cirrhosis Network: Scientific and Data Coordination Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $10,655,826 | August 28, 2021 | July 31, 2027 | SMITH, ABIGAIL | reporter.nih.gov |
| Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,550,278 | September 30, 2020 | July 31, 2026 | SPRINGER, SANDRA ANN | reporter.nih.gov |
| Kansas Center for Metabolism and Obesity REsearch (KC-MORE) | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $10,233,525 | April 1, 2022 | February 28, 2027 | WEINMAN, STEVEN A | reporter.nih.gov |
| Colorado Head and Neck Cancer SPORE | NIH | National Cancer Institute | 2021 to 2025 | $10,073,085 | September 1, 2021 | August 31, 2026 | JIMENO, ANTONIO | reporter.nih.gov |
| Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,070,868 | March 15, 2007 | November 30, 2027 | SUPPARATPINYO, KHUANCHAI | reporter.nih.gov |
| Southern Liver Health Cohort | NIH | National Cancer Institute | 2023 to 2025 | $10,038,112 | September 21, 2021 | August 31, 2027 | HOYO, CATHRINE | reporter.nih.gov |
| The Johns Hopkins University - Uganda Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,910,249 | February 5, 2007 | November 30, 2027 | FOWLER, MARY GLENN | reporter.nih.gov |
| Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $9,640,870 | August 26, 2021 | September 30, 2024 | LIMAYE, ABHIJIT PRAKASH | reporter.nih.gov |
| Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,632,234 | September 28, 2015 | June 30, 2030 | LI, LIANG | reporter.nih.gov |
| Determining the mechanism of pks+ E.coli-associated carcinogenesis in early onset colorectal cancer. | NIH | National Cancer Institute | 2022 to 2025 | $9,558,240 | September 20, 2022 | August 31, 2027 | O'REILLY, EILEEN MARY | reporter.nih.gov |
| Tissue destruction and healing in Celiac Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $9,512,977 | September 15, 2022 | July 31, 2027 | JABRI, BANA | reporter.nih.gov |
| Targeting the A2B Adenosine Receptor for Immunoprevention of Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2025 | $9,423,468 | September 15, 2023 | March 14, 2027 | WU, XIANGWEI | reporter.nih.gov |
| Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $9,412,704 | September 22, 2020 | June 30, 2026 | BURTNESS, BARBARA | reporter.nih.gov |
| Childhood Liver Disease Research Network (ChiLDReN) Scientific and Data Coordinating Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,404,513 | September 18, 2002 | May 31, 2029 | MAGEE, JOHN C | reporter.nih.gov |
| Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study | NIH | National Cancer Institute | 2021 to 2025 | $9,251,154 | September 19, 2016 | August 31, 2026 | ULRICH, CORNELIA M | reporter.nih.gov |
| COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepository | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,161,352 | September 15, 2019 | August 31, 2029 | MARTIN, MARTIN G | reporter.nih.gov |
| COBRE: Eukaryotic Pathogens Innovation Center (EPIC) | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $9,118,734 | July 15, 2022 | May 31, 2027 | MORRIS, JAMES CULVIN | reporter.nih.gov |
| Colon Cancer Family Registry Cohort | NIH | National Cancer Institute | 2021 to 2025 | $8,978,119 | May 1, 2013 | April 30, 2028 | JENKINS, MARK A | reporter.nih.gov |
| Statistical Methods for Integrative Genomics in Cancer | NIH | National Cancer Institute | 2021 to 2025 | $8,721,062 | July 1, 2016 | August 31, 2027 | GAUDERMAN, WILLIAM JAMES | reporter.nih.gov |
| Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Supporting Financial Sustainability, Advanced Methods, and Knowledge Translation | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,690,640 | July 15, 2015 | April 30, 2030 | SCHACKMAN, BRUCE R | reporter.nih.gov |
| Data Coordinating Center for the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Continuation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $8,663,508 | May 1, 2002 | June 30, 2028 | SHADE, DAVID M | reporter.nih.gov |
| dkNET Coordinating Unit: Harnessing the Power of AI and Data Science forCollaborative Discovery and Sharing in the DK Community | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $8,645,871 | December 1, 2012 | February 28, 2029 | GRETHE, JEFFREY S. | reporter.nih.gov |
| Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. Coli Infection (HIKO STEC): A Multinational, Embedded, Cluster, Crossover, Randomized Trial | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,451,589 | September 17, 2021 | August 31, 2027 | FREEDMAN, STEPHEN BRADLEY | reporter.nih.gov |
| Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn's Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $8,401,766 | April 1, 2023 | March 31, 2028 | HYAMS, JEFFREY SAMUEL | reporter.nih.gov |
| The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,239,326 | January 15, 2008 | November 30, 2027 | GRINSZTEJN, BEATRIZ | reporter.nih.gov |
| A Multicenter Randomized Controlled Trial of Surveillance versus. Endoscopic Therapy for Barretts Esophagus with Low-grade Dysplasia: The SURVENT Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $8,184,774 | May 15, 2022 | April 30, 2027 | WANI, SACHIN | reporter.nih.gov |
| Human Biomimetics for Mucosal Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,059,968 | March 15, 2015 | May 31, 2027 | ESTES, MARY KOLB | reporter.nih.gov |
| Precision IBD via genetics and genomics: integrating International and multi-omic datasets, expanding studies in diverse populations, and defining mechanisms of unmet clinical needs in IBD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,890,535 | September 30, 2002 | June 30, 2027 | CHO, JUDY H. | reporter.nih.gov |
| Columbia Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,800,557 | September 1, 2002 | December 31, 2027 | PAJVANI, UTPAL | reporter.nih.gov |
| Advanced Development and Clinical Evaluation of an Entamoeba Histolytica Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $7,788,182 | September 21, 2018 | November 22, 2025 | FOX, CHRISTOPHER | reporter.nih.gov |
| Stanford Tissue Mapping Center | NIH | National Human Genome Research Institute | 2022 to 2025 | $7,785,758 | September 23, 2022 | June 30, 2026 | SNYDER, MICHAEL P. | reporter.nih.gov |
| A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients (THINKER-NEXT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,767,541 | April 15, 2021 | March 31, 2027 | SCHAUBEL, DOUGLAS EARL | reporter.nih.gov |
| Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome | NIH | National Cancer Institute | 2022 to 2025 | $7,696,898 | September 20, 2022 | August 31, 2027 | GRADY, WILLIAM MALLORY | reporter.nih.gov |
| Base Title: PREVENT Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint BiomarkersTask Order Title: Colorectal Cancer (CRC) Prevention by TPST-1495 in PIRC rat mod | NIH | National Cancer Institute | 2021 to 2023 | $7,628,615 | September 11, 2023 | September 10, 2026 | RAO, CHINTHALAPALLY | reporter.nih.gov |
| Early Phase Clinical Cancer Prevention Consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,613,555 | July 7, 2020 | July 31, 2031 | SCHUETZE, SCOTT MICHAEL | reporter.nih.gov |
| Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $7,269,328 | March 15, 2023 | February 29, 2028 | DULAI, PARAMBIR SINGH | reporter.nih.gov |
| Identifying Immune and Epithelial Network Signatures in Very Early Onset Inflammatory Bowel Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $7,187,152 | September 15, 2020 | June 30, 2026 | SNAPPER, SCOTT B | reporter.nih.gov |
| Northwestern Cancer Prevention Consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,062,222 | September 3, 2019 | July 31, 2031 | KHAN, SEEMA AHSAN | reporter.nih.gov |
| Systems Biology of Early Atopy (SUNBEAM) Analysis and Bioinformatics Center | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $7,049,932 | December 8, 2022 | November 30, 2028 | BUNYAVANICH, SUPINDA | reporter.nih.gov |
| iCAN PREVENT: MD Anderson International Cancer Prevention Clinical Trials Consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,046,172 | August 15, 2019 | July 31, 2031 | VILAR SANCHEZ, EDUARDO | reporter.nih.gov |
| Personalized prime editing as a platform for hepatic inborn errors of metabolism | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $6,886,793 | September 20, 2024 | August 31, 2028 | AHRENS-NICKLAS, REBECCA CLARE | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,882,445 | September 29, 2025 | September 28, 2026 | WACTAWSKI-WENDE, JEAN | reporter.nih.gov |
| Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Markets and Drug Tourism | NIH | National Institute on Drug Abuse | 2021 to 2024 | $6,868,774 | April 1, 2020 | January 31, 2026 | STRATHDEE, STEFFANIE A. | reporter.nih.gov |
| MIST Early Career Scholar Awards in Mucosal Immunology | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,835,591 | July 25, 2011 | June 30, 2026 | ARTIS, DAVID | reporter.nih.gov |
| Subcutaneous Drug Development for Portal Hypertension Ascites | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,758,500 | September 22, 2014 | July 31, 2027 | CASTILLO, GERARDO M. | reporter.nih.gov |
| The oral environment in food allergy development (ONEIDA) | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $6,732,986 | August 1, 2025 | June 30, 2029 | BUNYAVANICH, SUPINDA | reporter.nih.gov |
| California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations | NIH | National Cancer Institute | 2021 to 2025 | $6,605,241 | September 12, 2019 | July 31, 2026 | PALEFSKY, JOEL MICHAEL | reporter.nih.gov |
| Integrated Epithelial and Muscosal Biology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,598,874 | September 1, 1997 | June 16, 2026 | LENCER, WAYNE I | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,534,889 | September 29, 2025 | September 28, 2026 | STEFANICK, MARCIA | reporter.nih.gov |
| SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $6,503,998 | August 14, 2020 | May 31, 2027 | NADEAU, KARI C. | reporter.nih.gov |
| Novel therapy for alcoholic liver disease-associated hepatorenal syndrome | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $6,485,223 | September 25, 2021 | August 31, 2027 | SUBRAMANIAN, MANI | reporter.nih.gov |
| Yale Liver Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,469,647 | September 30, 1997 | June 16, 2026 | NATHANSON, MICHAEL H | reporter.nih.gov |
| Decoding mechanisms underlying metabolic dysregulation in obesity and digestive cancer risk | NIH | National Cancer Institute | 2022 to 2025 | $6,443,697 | September 20, 2022 | August 31, 2027 | TOBIAS, DEIRDRE KAY | reporter.nih.gov |
| The Cleveland Digestive Diseases Research Core Center (DDRCC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,425,666 | February 15, 2015 | August 31, 2030 | COMINELLI, FABIO | reporter.nih.gov |
| Molecular and Cellular Basis for Digestive Diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,382,456 | June 15, 2002 | May 31, 2027 | PEEK, RICHARD M. | reporter.nih.gov |
| The spectrum of cognitive impairment including Alzheimer’s Disease and Related Dementias after liver transplantation | NIH | National Institute on Aging | 2021 to 2025 | $6,330,805 | June 15, 2018 | May 31, 2028 | LAI, JENNIFER C. | reporter.nih.gov |
| Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,330,175 | February 4, 2021 | January 31, 2026 | KAPPE, STEFAN HI | reporter.nih.gov |
| Mechanisms of Fecal Microbiota Transplant Protection from Recurrent C. difficile | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,326,957 | July 24, 2020 | June 30, 2029 | PETRI, WILLIAM A | reporter.nih.gov |
| The HIV and Alcohol Research center focused on Polypharmacy (HARP) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $6,323,238 | September 10, 2021 | August 31, 2026 | JUSTICE, AMY CAROLINE | reporter.nih.gov |
| BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIA | NIH | National Cancer Institute | 2022 to 2024 | $6,227,249 | June 15, 2022 | May 15, 2025 | CLAPPER, MARGIE L. | reporter.nih.gov |
| Pittsburgh Liver Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,209,773 | July 1, 2019 | March 31, 2029 | MONGA, SATDARSHAN SINGH | reporter.nih.gov |
| INSPPIRE: Using the natural history of pediatric chronic pancreatitis to identify disease predictors and design therapies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,195,043 | September 28, 2015 | June 30, 2030 | UC, ALIYE | reporter.nih.gov |
| INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients): The INSPIRE-ASP Trial for Intra-Abdominal and Skin and Soft Tissue Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $6,161,229 | June 19, 2020 | May 31, 2026 | PLATT, RICHARD | reporter.nih.gov |
| Ancillary Studies of NAFLD and NASH in HIV infected Adults | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $6,132,391 | March 21, 2020 | January 31, 2026 | CHALASANI, NAGA P | reporter.nih.gov |
| Host and microbial basis of human ulcerative colitis and pouchitis: Identification, role, mechanisms, and resource development of host susceptibility and pathobiont factors | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $6,122,586 | September 1, 2019 | May 31, 2025 | CHANG, EUGENE B | reporter.nih.gov |
| Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE) | NIH | National Cancer Institute | 2021 to 2023 | $6,108,355 | April 15, 2018 | March 31, 2025 | CORLEY, DOUGLAS ALLEN | reporter.nih.gov |
| Digestive Health Center (DHC): Bench to Bedside Research in Pediatric Digestive Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,096,518 | August 1, 2007 | May 31, 2027 | DENSON, LEE ARMISTEAD | reporter.nih.gov |
| PGpR2 Year 3 Supplement for the Scientific Data Research Center (SDRC) of the GpCRC 4 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,054,841 | May 1, 2006 | July 31, 2027 | SHADE, DAVID M | reporter.nih.gov |
| Johns Hopkins HIV Clinical Cohort | NIH | National Institute on Drug Abuse | 2021 to 2024 | $5,955,256 | July 1, 2014 | March 31, 2026 | MOORE, RICHARD DOUGLAS | reporter.nih.gov |
| Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico | NIH | National Cancer Institute | 2021 to 2025 | $5,948,066 | September 20, 2019 | July 31, 2026 | ELLSWORTH, GRANT B. | reporter.nih.gov |
| Spatial and temporal resolution to dissect cellular circuits controlling intestinal physiology, immunity, and inflammatory pathologies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $5,934,972 | August 1, 2023 | May 31, 2028 | XAVIER, RAMNIK J | reporter.nih.gov |
| Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $5,882,740 | August 26, 2021 | May 31, 2028 | LIMAYE, ABHIJIT PRAKASH | reporter.nih.gov |
| Identifying Microbial, Epithelial and Immune Cell Interactions that Mediate Mucosal Homeostasis and Determine IBD Phenotypes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $5,810,225 | September 19, 2013 | June 30, 2025 | SARTOR, RYAN B | reporter.nih.gov |
| Sjögren’s Team for Accelerating Medicines Partnership (STAMP) | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $5,801,518 | March 7, 2022 | December 31, 2026 | SHIBOSKI, CAROLINE HELENE | reporter.nih.gov |
| Host-environment interactions in the pathophysiology of digestive disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $5,753,874 | March 1, 2000 | July 31, 2030 | DAVIDSON, NICHOLAS O. | reporter.nih.gov |
| Rational design and efficacy testing of vaccines against HCV | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,737,237 | May 5, 2022 | April 30, 2027 | FUERST, THOMAS R | reporter.nih.gov |
| Histidine phosphorylation as a new target for cancer therapy | NIH | National Cancer Institute | 2021 to 2025 | $5,690,698 | September 18, 2019 | August 31, 2026 | HUNTER, TONY R. | reporter.nih.gov |
| Improvements to the Regional Biocontainment Research Facilities at the University of Missouri | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $5,667,997 | September 23, 2021 | February 28, 2025 | LORSON, CHRISTIAN L. | reporter.nih.gov |
| Food Allergy Management and Outcomes Related to Racial/Ethnic Differences from Infancy through Adolescence: The FORWARD Study | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,583,217 | May 11, 2017 | April 30, 2027 | GUPTA, RUCHI S | reporter.nih.gov |
| The role of stem cells and the microenvironment in gastrointestinal cancers | NIH | National Cancer Institute | 2021 to 2025 | $5,569,272 | January 7, 2016 | August 31, 2030 | WANG, TIMOTHY CRAGIN | reporter.nih.gov |
| MUSC Digestive Disease Research Core Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $5,554,374 | April 15, 2020 | August 31, 2030 | ROCKEY, DON C. | reporter.nih.gov |
| Cervical, Anal & Oral HPV Persistence/Adolescent Girls | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,549,203 | May 15, 2007 | January 31, 2028 | DIAZ, ANGELA | reporter.nih.gov |
| Effects of Intermittent Energy Restriction on Intra-Abdominal Fat and the Gut Microbiome: A Randomized Trial | NIH | National Cancer Institute | 2021 to 2025 | $5,478,236 | September 22, 2021 | August 31, 2026 | LE MARCHAND, LOIC | reporter.nih.gov |
| Determinants of inception of inflammation in inflammatory bowel diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $5,397,834 | August 24, 2021 | May 31, 2027 | ANANTHAKRISHNAN, ASHWIN N | reporter.nih.gov |
| 2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Center | NIH | National Cancer Institute | 2021 to 2025 | $5,355,395 | September 17, 2018 | August 31, 2028 | WILKIE, DIANA J | reporter.nih.gov |
| Chicago Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,330,849 | February 1, 2007 | November 30, 2027 | ACHENBACH, CHAD J | reporter.nih.gov |
| Cell plasticity in the origin of gastric carcinogenesis | NIH | National Cancer Institute | 2022 to 2025 | $5,262,457 | September 1, 2025 | August 31, 2027 | CHOI, EUNYOUNG | reporter.nih.gov |
| Innate immune sensors, inflammasomes, and inflammasome-mediated processes in cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,241,422 | July 21, 2020 | June 30, 2027 | KANNEGANTI, THIRUMALA-DEVI | reporter.nih.gov |
| Comparative Modeling of Effective Policies for Colorectal Cancer Control | NIH | National Cancer Institute | 2021 to 2025 | $5,238,594 | July 1, 2025 | August 31, 2026 | ZAUBER, ANN GRAHAM | reporter.nih.gov |
| Computational and Experimental Resources for Virome Analysis in Inflammatory Bowel Disease (CERVAID) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $5,235,383 | September 18, 2019 | June 30, 2025 | WANG, DAVID | reporter.nih.gov |
| Skin microbes and development of allergic disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $5,176,858 | September 5, 2025 | August 31, 2029 | GALLO, RICHARD L | reporter.nih.gov |
| A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,162,956 | March 25, 2022 | February 28, 2027 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| A Multimodal 3D Atlas of Colorectal Cancer Across Ages of Onset | NIH | National Cancer Institute | 2024 to 2025 | $5,159,940 | September 1, 2024 | August 31, 2029 | LAU, KEN S | reporter.nih.gov |
| Center for Gastric Pre-Cancer Atlas of Multidimensional Evolution in 3D (GAME3D) | NIH | National Cancer Institute | 2024 to 2025 | $5,158,661 | September 1, 2024 | August 31, 2029 | WANG, LINGHUA | reporter.nih.gov |
| High-throughput proteomics using submicroliter amounts of plasma for comprehensive assessment of the immune status | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,147,391 | April 9, 2020 | March 31, 2026 | STEEN, HANNO | reporter.nih.gov |
| Fecal Microbiota Transplantation and Fiber for the Treatment of Graft-versus-host Disease After Hematopoietic Cell Transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,128,451 | September 1, 2023 | June 30, 2027 | FREDRICKS, DAVID NEAL | reporter.nih.gov |
| Drug Induced Liver Injury Network Data Coordinating Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $5,081,421 | September 30, 2003 | July 31, 2028 | BARNHART, HUIMAN X | reporter.nih.gov |
| An atlas of pancreatic tumorigenesis in the context of altered DNA repair occurring in high-risk individuals | NIH | National Cancer Institute | 2024 to 2025 | $5,050,023 | September 1, 2024 | August 31, 2029 | SEARS, ROSALIE C | reporter.nih.gov |
| Molecular Mechanism of Mammalian DNA Excision Repair and the Circadian Clock | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $5,040,955 | April 1, 2016 | August 31, 2027 | SANCAR, AZIZ | reporter.nih.gov |
| Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $5,032,505 | September 21, 2024 | July 31, 2029 | JENQ, ROBERT | reporter.nih.gov |
| Utility of Random Biopsies in Inflammatory Bowel Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $5,031,513 | July 1, 2024 | June 30, 2029 | LEWIS, JAMES D | reporter.nih.gov |
| Pancreatic Cancer Detection Consortium | NIH | National Cancer Institute | 2021 to 2025 | $5,023,372 | May 1, 2017 | August 31, 2027 | HOLLINGSWORTH, MICHAEL A. | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,000,825 | September 29, 2025 | September 28, 2026 | JACKSON, REBECCA | reporter.nih.gov |
| Gastroesophageal junction stem cells as the origin of Barretts esophagus and cancer | NIH | National Cancer Institute | 2022 to 2025 | $4,948,268 | September 1, 2025 | August 31, 2027 | WANG, TIMOTHY CRAGIN | reporter.nih.gov |
| Bacteriophage-based approach for managing Shigella infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,946,719 | May 5, 2020 | April 30, 2026 | SULAKVELIDZE, ALEXANDER | reporter.nih.gov |
| Reprogramming the Tumor-Immune Interface in Oral Cancer | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $4,940,407 | September 8, 2020 | June 30, 2028 | SUNWOO, JOHN B | reporter.nih.gov |
| Dose-response of aerobic training during total neoadjuvant therapy for locally advanced rectal cancer | NIH | National Cancer Institute | 2022 to 2025 | $4,937,681 | May 6, 2022 | April 30, 2027 | SCOTT, JESSICA | reporter.nih.gov |
| Targeting the MYC Pathway for the Treatment of Cancer | NIH | National Cancer Institute | 2021 to 2025 | $4,931,456 | September 8, 2020 | August 31, 2027 | FELSHER, DEAN W | reporter.nih.gov |
| Intervention to Reduce Early (Peanut) Allergy in Children (iREACH) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,923,573 | July 24, 2019 | June 30, 2025 | GUPTA, RUCHI S | reporter.nih.gov |
| Precision Prevention Research Program | NIH | National Cancer Institute | 2021 to 2025 | $4,849,798 | September 1, 2020 | August 31, 2027 | CHAN, ANDREW T | reporter.nih.gov |
| Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images | NIH | National Cancer Institute | 2021 to 2025 | $4,827,743 | September 1, 2021 | August 31, 2026 | LI, DEBIAO | reporter.nih.gov |
| Great Lakes New England Clinical Validation Center | NIH | National Cancer Institute | 2022 to 2025 | $4,820,800 | May 15, 2000 | August 31, 2027 | RICCIARDIELLO, LUIGI | reporter.nih.gov |
| Endosomal mechanisms signaling oral cancer pain | NIH | National Institute of Dental & Craniofacial Research | 2023 | $4,820,611 | September 19, 2023 | August 31, 2026 | SCHMIDT, BRIAN L | reporter.nih.gov |
| Establishing patient-derived iPSCs as a platform for discovery research in NAFLD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $4,780,391 | June 1, 2023 | March 31, 2028 | MAHER, JACQUELYN J. | reporter.nih.gov |
| Metabolic Influences on Complex Tumor Neighborhoods | NIH | National Cancer Institute | 2021 to 2025 | $4,722,150 | August 1, 2017 | July 31, 2030 | SIMON, M. CELESTE | reporter.nih.gov |
| Defining mechanisms driving salivary gland regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $4,717,861 | September 18, 2018 | June 30, 2026 | KNOX, SARAH MONICA | reporter.nih.gov |
| Development of Non-Human Primate Models to Assess Immunological Mechanisms and Antigenic Targets of Protective Sporozoite (SPZ) Vaccines and Establish Superior Efficacy of Next Generation SPZ vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,717,265 | April 1, 2021 | March 31, 2027 | HOFFMAN, STEPHEN LEV | reporter.nih.gov |
| Targeting hepatic stellate cell metabolism to treat steatotic liver disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,674,973 | April 1, 2015 | August 31, 2029 | FINCK, BRIAN N | reporter.nih.gov |
| Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,664,222 | August 1, 2021 | May 31, 2027 | ALTICE, FREDERICK LEWIS | reporter.nih.gov |
| Live-cell Activity Architecture in Cancer | NIH | National Cancer Institute | 2021 to 2025 | $4,655,641 | August 1, 2015 | July 31, 2029 | ZHANG, JIN | reporter.nih.gov |
| Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity | NIH | National Cancer Institute | 2021 to 2025 | $4,635,563 | September 1, 2021 | August 31, 2027 | TUSSING-HUMPHREYS, LISA | reporter.nih.gov |
| IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,621,686 | July 1, 1984 | May 31, 2028 | PLATTS-MILLS, THOMAS A. | reporter.nih.gov |
| Early to Late Events in Colorectal Neoplasia: Basic Biology to Clinical Implementation | NIH | National Cancer Institute | 2021 to 2025 | $4,608,771 | April 1, 2017 | July 31, 2031 | COFFEY, ROBERT J. | reporter.nih.gov |
| Non-alcoholic Fatty Liver Disease and Cardiovascular Disease in Hispanics/Latinos | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $4,589,716 | September 1, 2019 | August 31, 2024 | KIZER, JORGE R | reporter.nih.gov |
| Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $4,582,323 | September 20, 2018 | July 31, 2024 | STAHL, ANDREAS | reporter.nih.gov |
| Tissue factor-dependent coagulation in thrombosis and immune responses | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,577,076 | February 1, 2021 | January 31, 2028 | MACKMAN, NIGEL | reporter.nih.gov |
| Mechanisms underlying gastric intestinal metaplasia and carcinogenesis | NIH | National Cancer Institute | 2022 to 2025 | $4,560,310 | September 20, 2022 | August 31, 2027 | RUSTGI, ANIL K | reporter.nih.gov |
| Coordinate Regulation of Virulence in Vibrio Cholerae | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,541,366 | July 1, 1981 | March 31, 2029 | MEKALANOS, JOHN JOSEPH | reporter.nih.gov |
| Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy | NIH | National Cancer Institute | 2021 to 2025 | $4,541,273 | September 17, 2019 | August 31, 2026 | TING, JENNY P | reporter.nih.gov |
| Support for the Central Data Collection Center (CDCC) | NIH | National Cancer Institute | 2021 to 2025 | $4,460,745 | February 27, 2021 | February 26, 2025 | MATHEW, SUNITHA | reporter.nih.gov |
| Early Pathogenesis of Cystic Fibrosis Related Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $4,452,977 | April 30, 2021 | March 31, 2024 | ENGELHARDT, JOHN F | reporter.nih.gov |
| Increasing Access to Hepatitis C Treatment in Opioid Endemic Rural Areas: the Kentucky Viral Hepatitis Treatment (KeY Treat) Study | NIH | National Institute on Drug Abuse | 2021 to 2023 | $4,371,481 | September 30, 2018 | July 31, 2025 | HAVENS, JENNIFER R | reporter.nih.gov |
| Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $4,324,679 | September 20, 2018 | July 31, 2023 | TAYLOR, D. LANSING | reporter.nih.gov |
| Porphyrias Consortium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $4,280,404 | September 30, 2009 | June 30, 2025 | DESNICK, ROBERT J | reporter.nih.gov |
| The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors | NIH | National Cancer Institute | 2021 to 2025 | $4,277,018 | September 1, 2021 | August 31, 2027 | SIGEL, KEITH MAGNUS | reporter.nih.gov |
| Live cell reporters of genetic changes in stiff vs soft surroundings - Causes & Consequences | NIH | National Cancer Institute | 2021 to 2025 | $4,251,467 | April 1, 2021 | March 31, 2026 | DISCHER, DENNIS E. | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,249,024 | September 29, 2025 | September 28, 2026 | VITOLINS, MARA | reporter.nih.gov |
| Xenobiotic Receptors in Mediating the Environmental Effects on Human Disease and Morbidity | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $4,237,518 | August 1, 2019 | May 31, 2027 | XIE, WEN | reporter.nih.gov |
| Cytokine regulation of mucosal inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,234,402 | June 6, 2019 | June 30, 2029 | SONNENBERG, GREGORY F | reporter.nih.gov |
| The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,204,220 | May 15, 2015 | June 30, 2030 | FLEXNER, CHARLES W. | reporter.nih.gov |
| Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $4,185,542 | September 15, 2023 | June 30, 2028 | LEBWOHL, BENJAMIN | reporter.nih.gov |
| Integrating HCV services into HIV programs for PWID in India | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,184,487 | July 8, 2019 | June 30, 2025 | MEHTA, SHRUTI H | reporter.nih.gov |
| Leveraging Omics and Electronic Health Records Data to study Colorectal Adenoma genetics and Drug Repurposing | NIH | National Cancer Institute | 2025 | $4,174,595 | September 10, 2025 | August 31, 2029 | GUO, XINGYI | reporter.nih.gov |
| Structural Analysis and Inhibitor Optimization of Cryptosporidium n-myristoyltransferase for Drug Discovery | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,163,372 | November 15, 2020 | October 31, 2026 | STAKER, BART LEE | reporter.nih.gov |
| Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators | NIH | National Cancer Institute | 2021 to 2025 | $4,123,295 | June 15, 2021 | August 31, 2026 | FIGUEIREDO, JANE C. | reporter.nih.gov |
| The role of CD40L in resistance to enteric infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,118,859 | August 17, 2021 | May 31, 2026 | HUNTER, CHRISTOPHER A | reporter.nih.gov |
| Development of an oral liver-targeted prime-and-trap malaria vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,104,491 | December 1, 2020 | November 30, 2026 | MURPHY, SEAN C | reporter.nih.gov |
| Altered metabolism and machine learning for pancreatic cancer early detection | NIH | National Cancer Institute | 2021 to 2025 | $4,100,528 | September 16, 2022 | August 31, 2027 | WOLPIN, BRIAN MATTHEW | reporter.nih.gov |
| The small intestinal microbiota in undernourished women and undernourished children in Bangladesh: identifying causal mechanisms and therapeutic targets | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $4,099,868 | September 21, 2021 | May 31, 2026 | GORDON, JEFFREY I | reporter.nih.gov |
| Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity | NIH | National Cancer Institute | 2022 to 2025 | $4,096,241 | September 19, 2022 | August 31, 2027 | HAHN, WILLIAM C. | reporter.nih.gov |
| CRC-HUB-SPOKE: A ColoRectal Cancer screening Hub for Southern California community health centers. | NIH | National Cancer Institute | 2021 to 2023 | $4,080,149 | September 19, 2019 | August 31, 2025 | MARTINEZ, MARIA ELENA | reporter.nih.gov |
| Initiation of Diffuse and Intestinal Non-Cardia Gastric Cancer | NIH | National Cancer Institute | 2022 to 2025 | $4,080,056 | September 1, 2025 | August 31, 2027 | RYEOM, SANDRA | reporter.nih.gov |
| RADx Innovation Funnel for Hepatitis B Diagnostics - Coordination Center | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,074,004 | September 30, 2024 | September 29, 2026 | SCHACHTER, STEVEN C. | reporter.nih.gov |
| Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2025 | $4,072,882 | September 1, 2017 | July 31, 2028 | GOEL, AJAY | reporter.nih.gov |
| Optimization of Lead BKIs for Cryptosporidiosis Therapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,065,300 | January 1, 2021 | December 31, 2026 | VAN VOORHIS, WESLEY C | reporter.nih.gov |
| Comparative modeling of gastric cancer health drivers and prevention in the US and globally | NIH | National Cancer Institute | 2021 to 2025 | $4,054,972 | September 15, 2021 | August 31, 2026 | HUR, CHIN | reporter.nih.gov |
| A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers | NIH | National Cancer Institute | 2021 to 2025 | $4,028,888 | March 3, 2020 | March 31, 2030 | LEE, NANCY Y | reporter.nih.gov |
| Improving Survival in Oral Cancer by Disruption of Tumor Progression | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $4,021,748 | September 14, 2017 | June 30, 2025 | D'SILVA, NISHA J | reporter.nih.gov |
| Disambiguating natural aging from Alzheimer's disease through changes in oral neuromechanics | NIH | National Institute on Aging | 2022 to 2024 | $4,016,586 | September 15, 2020 | May 31, 2026 | ARCE-MCSHANE, FRITZIE ISIP | reporter.nih.gov |
| Implantable iontophoresis chemotherapy delivery device for direct infusion ofgemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial | NIH | National Cancer Institute | 2021 to 2022 | $4,000,000 | September 17, 2017 | July 31, 2024 | DAUNCH, WILLIAM ANDREW | reporter.nih.gov |
| Consortium on Intestinal Regeneration and Fetal Reversion: from Atlas to Therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $4,000,000 | September 1, 2024 | June 30, 2029 | KLEIN, OPHIR D | reporter.nih.gov |
| Commercializing CivaSheet for Pancreatic Cancer Patients | NIH | National Cancer Institute | 2023 to 2025 | $3,999,206 | September 13, 2016 | June 30, 2026 | PEREZ, KRISTY | reporter.nih.gov |
| Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma | NIH | National Cancer Institute | 2021 to 2025 | $3,998,452 | May 17, 2016 | March 31, 2028 | BRAND, RANDALL | reporter.nih.gov |
| Development of a protein drug for pancreatic cancer treatment | NIH | National Cancer Institute | 2022 to 2024 | $3,994,217 | September 26, 2017 | January 31, 2025 | LIU, ZHI-REN | reporter.nih.gov |
| A novel diagnostic Kit for Hepatocellular Carcinoma | NIH | National Cancer Institute | 2021 to 2023 | $3,993,675 | September 1, 2012 | August 31, 2025 | LU, XUANYONG | reporter.nih.gov |
| Identifying Metabolic Dependencies of Pancreatic Cancers | NIH | National Cancer Institute | 2021 to 2024 | $3,975,118 | August 1, 2018 | July 31, 2025 | KIMMELMAN, ALEC | reporter.nih.gov |
| Is Obesity an Infectious Disease?: Gut bacterial and fungal translocation as an underappreciated driver of visceral adipose expansion. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,971,090 | September 30, 2021 | June 30, 2026 | DEVKOTA, SUZANNE | reporter.nih.gov |
| IL-10NanoCap® for Therapy of Familial Adenomatous Polyposis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,969,244 | March 7, 2019 | March 31, 2026 | AUCI, DOMINICK | reporter.nih.gov |
| Ceramides as novel drivers of metabolic dysfunction and colorectal cancer | NIH | National Cancer Institute | 2022 to 2025 | $3,957,452 | September 2, 2022 | August 31, 2027 | PLAYDON, MARY CHRISTINE | reporter.nih.gov |
| Targeting HB-EGF and trigeminal EGFR for oral cancer pain and opioid tolerance | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $3,950,748 | September 19, 2022 | September 18, 2027 | YE, YI | reporter.nih.gov |
| Gut barrier function in Alzheimer’s disease | NIH | National Institute on Aging | 2021 to 2025 | $3,945,245 | February 15, 2021 | January 31, 2026 | BENDLIN, BARBARA BRIGITTA | reporter.nih.gov |
| Molecular basis of bioelectronic medicine | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,937,630 | May 1, 2016 | April 30, 2027 | TRACEY, KEVIN J | reporter.nih.gov |
| Cardiovascular disease, metabolic syndrome, microbes and metabolites in FHS | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,935,193 | February 1, 2022 | January 31, 2027 | XAVIER, RAMNIK J | reporter.nih.gov |
| Fibroblast Heterogeneity in Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,931,956 | August 10, 2021 | July 31, 2026 | TUVESON, DAVID A | reporter.nih.gov |
| A systems immunology approach for predicting poor responses to Hepatitis B vaccination | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,925,255 | September 17, 2021 | August 31, 2026 | HERATI, RAMIN | reporter.nih.gov |
| Interrogating the Evolutionary Dynamics of Cancer for Clinical Benefit and Actionability | NIH | National Cancer Institute | 2021 to 2024 | $3,915,629 | August 1, 2018 | July 31, 2025 | IACOBUZIO-DONAHUE, CHRISTINE A | reporter.nih.gov |
| Next-generation human liver gene therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,896,814 | September 30, 2021 | June 30, 2027 | WILLENBRING, HOLGER | reporter.nih.gov |
| Elucidation and targeting of paracrine cascades in PDAC | NIH | National Cancer Institute | 2022 to 2025 | $3,892,796 | September 1, 2022 | August 31, 2027 | OLIVE, KENNETH P. | reporter.nih.gov |
| Targeting Succinate Signaling for Innovative Pain Relief in Oral Cancer. | NIH | National Institute of Dental & Craniofacial Research | 2025 | $3,892,146 | September 1, 2025 | August 31, 2029 | LI, XIN | reporter.nih.gov |
| Dietary and synbiotic strategy to limit gut microbiome dysbiosis and protect against Clostridioides difficile infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,880,251 | April 23, 2021 | March 31, 2027 | LOZUPONE, CATHERINE | reporter.nih.gov |
| HIV Persistence and Renewal in the Gastrointestinal, Genitourinary and Adipose Tissues | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,879,562 | September 17, 2021 | July 31, 2026 | SMITH, DAVID MITCHELL | reporter.nih.gov |
| Making Better Decisions: Policy Modeling for AIDS and Drug Abuse | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,865,844 | September 25, 2022 | January 31, 2029 | OWENS, DOUGLAS K | reporter.nih.gov |
| Development of small molecule inhibitors of metabolic enzymes as broad spectrum anthelmintic drugs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,860,924 | March 11, 2021 | February 28, 2027 | MITREVA, MAKEDONKA | reporter.nih.gov |
| Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules | NIH | National Cancer Institute | 2023 to 2025 | $3,858,633 | September 19, 2023 | August 31, 2028 | SINGAL, AMIT | reporter.nih.gov |
| Macrophage Polarization in Response to Infections and Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,855,235 | September 22, 2020 | August 31, 2025 | GHOSH, PRADIPTA | reporter.nih.gov |
| Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation | NIH | National Cancer Institute | 2022 to 2025 | $3,855,091 | September 22, 2022 | August 31, 2027 | MARKOWITZ, SANFORD D. | reporter.nih.gov |
| Developing broad-spectrum therapeutics against C. difficile toxins | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,852,231 | February 11, 2021 | January 31, 2027 | JIN, RONGSHENG | reporter.nih.gov |
| Mechanisms and pathophysiologic impact of claudin-2 modulation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,845,865 | September 29, 2001 | June 30, 2028 | TURNER, JERROLD R. | reporter.nih.gov |
| Mechanisms of protection against shigellosis in children | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,843,317 | June 9, 2022 | May 31, 2027 | PASETTI, MARCELA F | reporter.nih.gov |
| A Rhesus Macaque Model of HIV and HBV co-infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,842,980 | March 20, 2021 | February 28, 2026 | BURWITZ, BENJAMIN J | reporter.nih.gov |
| Molecular mechanisms underlying HIV related intestinal epithelial barrier dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,842,606 | August 1, 2021 | December 31, 2026 | PARKOS, CHARLES A | reporter.nih.gov |
| The UCLA Center in Early Detection of Liver Cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,825,539 | September 17, 2018 | August 31, 2028 | ZHOU, XIANGHONG JASMINE | reporter.nih.gov |
| Functional profiling of OSP-specific and other antibodies during shigella infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,818,268 | September 22, 2020 | August 31, 2030 | RYAN, EDWARD T. | reporter.nih.gov |
| GEMS: Genomic approach to connecting Elevated germline Mutation rates with male infertility and Somatic health | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,803,952 | September 1, 2021 | May 31, 2027 | HOTALING, JAMES | reporter.nih.gov |
| B cell memory in human food allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,793,314 | June 9, 2021 | December 31, 2026 | CUROTTO DE LAFAILLE, MARIA A | reporter.nih.gov |
| Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy | NIH | National Cancer Institute | 2021 to 2024 | $3,779,781 | August 15, 2018 | July 31, 2025 | GRANDIS, JENNIFER RUBIN | reporter.nih.gov |
| Columbus NCORP RFA-CA-18-016 | NIH | National Cancer Institute | 2021 to 2025 | $3,771,688 | August 1, 2014 | July 31, 2026 | RAJAGOPALAN, MALOLAN S | reporter.nih.gov |
| Optimization of a remote intervention to improve nutrition and physical activity in colorectal cancer survivors | NIH | National Cancer Institute | 2021 to 2025 | $3,771,145 | December 10, 2020 | November 30, 2025 | VAN BLARIGAN, ERIN LYNN | reporter.nih.gov |
| Human natural killer cells: Advancing biology and clinical applications | NIH | National Cancer Institute | 2021 to 2025 | $3,769,374 | July 21, 2017 | June 30, 2032 | CALIGIURI, MICHAEL A | reporter.nih.gov |
| Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,767,699 | July 15, 2016 | August 31, 2027 | MAJUMDER, SHOUNAK | reporter.nih.gov |
| Defining the lymphatic basis of protein losing enteropathy after Fontan palliation or inflammatory gut disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,759,375 | September 30, 2021 | June 30, 2027 | RANDOLPH, GWENDALYN J | reporter.nih.gov |
| O-Specific Polysaccharide Responses and Cholera | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,758,033 | August 7, 2013 | March 31, 2030 | RYAN, EDWARD T. | reporter.nih.gov |
| Spatio-temporal Methods for Surveillance of the Opioid Syndemic | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,748,657 | September 1, 2025 | August 31, 2029 | KLINE, DAVID M | reporter.nih.gov |
| Immunity to Cryptosporidium | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,739,027 | January 1, 2020 | December 31, 2029 | HUNTER, CHRISTOPHER A | reporter.nih.gov |
| Rational Integration of Polygenic Risk Scores (RIPS) | NIH | National Human Genome Research Institute | 2022 to 2025 | $3,737,256 | March 10, 2022 | February 28, 2027 | PETERSON, JOSEPH F. | reporter.nih.gov |
| Clinical Validation Center for Hepatocellular Carcinoma | NIH | National Cancer Institute | 2022 to 2025 | $3,730,583 | August 3, 2022 | July 31, 2027 | SINGAL, AMIT | reporter.nih.gov |
| Enteric Pathogen Force of Infection among Children using Serology | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,719,600 | July 1, 2021 | June 30, 2027 | ARNOLD, BENJAMIN F | reporter.nih.gov |
| Pathogenesis of youth onset pre-diabetes and Type 2 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,716,431 | September 22, 2016 | July 31, 2026 | CAPRIO, SONIA | reporter.nih.gov |
| HAWAII CLINICAL RESEARCH NETWORK FOR HEALTH EQUITY | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $3,711,764 | September 24, 2022 | November 30, 2027 | SHIKUMA, CECILIA M. | reporter.nih.gov |
| Identification and Characterization of Entry Factors Critical for Rift Valley Fever Virus Infection and Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,704,381 | March 19, 2021 | February 28, 2027 | AMARASINGHE, GAYA K. | reporter.nih.gov |
| Conduct Synthesis and Acquire Batches of Compounds for Subsequent Biological In Vitro and In Vivo Testing | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,702,250 | April 1, 2024 | March 31, 2025 | MIDDLETON, MARK | reporter.nih.gov |
| Gastroschisis Outcomes of Delivery (GOOD) Study | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,695,902 | April 13, 2021 | March 31, 2027 | WAGNER, AMY J | reporter.nih.gov |
| Restoring Central Regulation of Glucose Production in Type 2 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,695,446 | June 15, 2006 | April 30, 2027 | HAWKINS, MEREDITH A | reporter.nih.gov |
| THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATION | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,689,371 | July 16, 2012 | May 31, 2027 | BAKER, OLGA JULIANA | reporter.nih.gov |
| Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health Outcomes | NIH | National Cancer Institute | 2021 to 2025 | $3,678,371 | September 7, 2021 | August 31, 2026 | YUAN, JIAN-MIN | reporter.nih.gov |
| Look inward: brainstem and cortical circuits for boosting interoceptive attention | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $3,675,000 | September 30, 2019 | July 31, 2025 | ANDERMANN, MARK L | reporter.nih.gov |
| Blood-Based Testing for Advanced Adenoma | NIH | National Cancer Institute | 2022 to 2025 | $3,665,539 | September 12, 2022 | February 29, 2028 | SCHOEN, ROBERT E. | reporter.nih.gov |
| Enhancing immune regulation in gene therapy for hemophilia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,664,714 | July 1, 2016 | June 30, 2029 | HERZOG, ROLAND W. | reporter.nih.gov |
| Studying factors controlling cancer progression and immune recognition in mouse models | NIH | National Cancer Institute | 2022 to 2025 | $3,664,660 | September 20, 2022 | August 31, 2029 | JACKS, TYLER E. | reporter.nih.gov |
| Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,664,508 | September 20, 2022 | June 30, 2027 | KULKARNI, ROHIT N. | reporter.nih.gov |
| Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention. | NIH | National Cancer Institute | 2021 to 2025 | $3,654,173 | April 5, 2021 | March 31, 2027 | CHAN, ANDREW T | reporter.nih.gov |
| Trial of Statins for Chemoprevention in Hepatocellular Carcinoma | NIH | National Cancer Institute | 2021 to 2025 | $3,646,155 | September 1, 2021 | August 31, 2027 | CHUNG, RAYMOND T | reporter.nih.gov |
| Using markers to improve pancreatic cancer screening and surveillance: a multi-center study | NIH | National Cancer Institute | 2021 to 2025 | $3,641,472 | July 18, 2016 | August 31, 2027 | GOGGINS, MICHAEL G. | reporter.nih.gov |
| Molecular strategies for early detection and targeting of cancer | NIH | National Cancer Institute | 2022 to 2025 | $3,640,759 | August 12, 2015 | July 31, 2028 | REYA, TANNISHTHA | reporter.nih.gov |
| Estrogen Administration for the Treatment of NASH in Postmenopausal Women | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,638,994 | August 1, 2021 | May 31, 2027 | MILLER, KAREN K | reporter.nih.gov |
| IND Enabling Studies and Manufacturing Scale Up of Human Placental Extract to Prevent Surgical Necrotizing Enterocolitis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,623,857 | July 2, 2020 | May 31, 2027 | BERGER, MICHAEL BENTLEY | reporter.nih.gov |
| Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,618,437 | September 1, 2016 | June 30, 2026 | COOPER, STEWART | reporter.nih.gov |
| Research Training in Digestive Diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,607,280 | July 1, 1976 | June 30, 2026 | CHUNG, RAYMOND T | reporter.nih.gov |
| Role of the Epitranscriptome in Cancer | NIH | National Cancer Institute | 2021 to 2024 | $3,597,010 | August 1, 2019 | November 30, 2024 | GREGORY, RICHARD I. | reporter.nih.gov |
| Mechanisms associated with flares and remission in colitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,593,722 | May 1, 2017 | May 31, 2026 | LIRA, SERGIO A. | reporter.nih.gov |
| NIH: Spatial Models of Intrahepatic Hepatitis Virus Propagation in Humans | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,593,236 | February 7, 2022 | January 31, 2027 | RIBEIRO, RUY M | reporter.nih.gov |
| Type IV Protein Secretion in Helicobacter pylori | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,592,685 | February 18, 2016 | March 31, 2027 | COVER, TIMOTHY L | reporter.nih.gov |
| Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology | NIH | National Cancer Institute | 2021 to 2025 | $3,589,331 | July 1, 2019 | August 31, 2026 | PERMUTH, JENNIFER B | reporter.nih.gov |
| Targeting undruggable RAS for cancer treatment | NIH | National Cancer Institute | 2021 to 2024 | $3,589,157 | September 1, 2018 | August 31, 2025 | DER, CHANNING J. | reporter.nih.gov |
| Genetics, Epigenetics, and Risk Prediction for Esophageal Adenocarcinoma | NIH | National Cancer Institute | 2022 to 2025 | $3,588,780 | September 12, 2022 | August 31, 2027 | KOOPERBERG, CHARLES L | reporter.nih.gov |
| Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal | NIH | National Cancer Institute | 2021 to 2025 | $3,585,446 | July 1, 2010 | June 30, 2027 | NAKAGAWA, MAYUMI | reporter.nih.gov |
| Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,584,464 | June 15, 2022 | March 31, 2027 | ELLIS, RONALD J. | reporter.nih.gov |
| Establishing Reference Values and Clinical Decision Points for Quantitative Videofluoroscopic Measures of Swallowing | NIH | National Institute on Aging | 2022 to 2025 | $3,572,615 | August 1, 2010 | July 31, 2027 | STEELE, CATRIONA MARGARET | reporter.nih.gov |
| Effectiveness and implementation of a health system intervention to improve quality of cancer care for rural, underserved patients | NIH | National Cancer Institute | 2021 to 2025 | $3,568,895 | April 1, 2021 | March 31, 2027 | CHARLTON, MARY E. | reporter.nih.gov |
| Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,563,506 | August 7, 2018 | July 31, 2029 | SEN, SUBRATA | reporter.nih.gov |
| A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer | NIH | National Cancer Institute | 2022 to 2025 | $3,558,479 | August 16, 2022 | July 31, 2028 | HEBERT, JAMES R | reporter.nih.gov |
| Assessing the effects of oral pre-exposure prophylaxis on pharmacokinetics of monoclonal and vaccine-induced antibodies among women vulnerable to HIV-1 | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,554,273 | September 12, 2025 | August 31, 2029 | HUANG, YUNDA | reporter.nih.gov |
| Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy | NIH | National Cancer Institute | 2021 to 2025 | $3,549,010 | July 8, 2021 | February 28, 2027 | SHARMA, SONIA | reporter.nih.gov |
| Interactions between neutrophils and cholangiocytes in alcoholic hepatitis | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $3,548,231 | September 25, 2021 | June 30, 2027 | NATHANSON, MICHAEL H | reporter.nih.gov |
| Preventing GVHD by inhibition of alloantigen presentation in the gut | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,543,040 | July 1, 2019 | June 30, 2027 | HILL, GEOFFREY ROGER | reporter.nih.gov |
| Translating Scientific Evidence into Practice using Digital Medicine and Electronic Patient Reported Outcomes | NIH | National Center for Advancing Translational Sciences | 2021 to 2023 | $3,537,149 | April 20, 2020 | March 31, 2025 | SANDS, BRUCE E | reporter.nih.gov |
| University of California and UT Southwestern D-PDTC | NIH | National Cancer Institute | 2023 to 2025 | $3,532,429 | August 1, 2023 | July 31, 2028 | CARVAJAL CARMONA, LUIS GUILLERMO | reporter.nih.gov |
| Risk Stratification for and Early Detection of Liver Cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,531,567 | September 13, 2018 | August 31, 2028 | KANWAL, FASIHA | reporter.nih.gov |
| Targeting the Intestinal Mucosa and Microbiome to Prevent Neonatal Late-onset Sepsis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,526,115 | August 1, 2021 | July 31, 2027 | WEAVER, CASEY T | reporter.nih.gov |
| Impact of the COVID-19 pandemic on patient outcomes, telehealth care delivery, and treatment for unhealthy alcohol use in vulnerable patients with advanced liver disease across two healthcare systems | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $3,517,747 | June 1, 2021 | February 28, 2027 | KHALILI, MANDANA | reporter.nih.gov |
| Acute/chronic limitations to transcriptional RNAi therapies for infectious and other liver diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,515,317 | August 1, 2006 | July 31, 2026 | KAY, MARK A | reporter.nih.gov |
| Control of intestinal innate immunity by the commensal microbiota in a model host | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,511,902 | September 24, 2021 | August 31, 2027 | WATNICK, PAULA I | reporter.nih.gov |
| Structural and Mechanistic basis for RNA Silencing | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,507,599 | August 1, 2018 | July 31, 2028 | MACRAE, IAN JOHN | reporter.nih.gov |
| Host-pathogen interactions in experimental cholera | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,506,027 | January 1, 1998 | May 31, 2027 | WALDOR, MATTHEW K | reporter.nih.gov |
| Clinical Center for Cholestatic Liver Disease in Children | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,505,921 | September 15, 2002 | May 31, 2029 | MIETHKE, ALEXANDER | reporter.nih.gov |
| Analysis of the Metabolic Capabilities of Prokaryotic Cells | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,499,962 | March 1, 2019 | March 31, 2029 | ESCALANTE, JORGE C | reporter.nih.gov |
| Variation in tumor-associated immune profiles and colorectal cancer outcomes | NIH | National Cancer Institute | 2021 to 2025 | $3,497,316 | September 15, 2021 | August 31, 2027 | SCHMIT, STEPHANIE L. | reporter.nih.gov |
| Biochemical and cellular mechanisms linking actin mutations to visceral myopathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,487,348 | September 28, 2021 | August 31, 2027 | HEUCKEROTH, ROBERT O | reporter.nih.gov |
| SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $3,482,713 | August 14, 2020 | January 13, 2023 | NADEAU, KARI C. | reporter.nih.gov |
| Soil epidemiology: a new tool for environmental surveillance of soil-transmitted helminth infections in endemic settings. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,480,159 | July 1, 2025 | June 30, 2027 | PICKERING, AMY J. | reporter.nih.gov |
| Evaluation of Memory Responses and Biomarkers from a Phase IEnterotoxigenic Escherichia coli (ETEC) Intramuscular SubunitVaccine with dmLT Adjuvant | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,467,638 | September 24, 2021 | August 31, 2026 | NORTON, ELIZABETH B | reporter.nih.gov |
| Role of Transglutaminase 2 in Celiac Sprue | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,463,787 | September 20, 2003 | April 30, 2026 | KHOSLA, CHAITAN | reporter.nih.gov |
| Abbreviated MRI for HCC screening in cirrhotic patients | NIH | National Cancer Institute | 2021 to 2024 | $3,461,079 | June 19, 2020 | May 31, 2026 | TAOULI, BACHIR | reporter.nih.gov |
| AcetaSTAT Validation and Commercialization | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,458,961 | April 1, 2008 | March 31, 2026 | JAMES, LAURA P | reporter.nih.gov |
| Innate Immune Defense Mechanisms in the Intestine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,458,283 | August 1, 2014 | November 30, 2026 | REINECKER, HANS-CHRISTIAN | reporter.nih.gov |
| A Phase 1-2 clinical program for the teatment of Microsatellite Stable Colorectal Cancer with the combination of SR-8541A, Botensilimab, and Balstilimab | NIH | National Cancer Institute | 2022 to 2025 | $3,457,194 | August 14, 2025 | July 31, 2028 | KAADIGE, MOHAN RAO | reporter.nih.gov |
| Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,455,616 | February 11, 2020 | January 31, 2026 | ROBINSON-PAPP, JESSICA | reporter.nih.gov |
| The MYC Transcription Factor Network and the Path to Cancer | NIH | National Cancer Institute | 2021 to 2024 | $3,449,610 | September 1, 2018 | August 31, 2025 | EISENMAN, ROBERT NEIL | reporter.nih.gov |
| Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma | NIH | National Cancer Institute | 2023 to 2025 | $3,449,390 | September 18, 2023 | August 31, 2028 | KUHN, PETER | reporter.nih.gov |
| Vibrio cholerae quorum sensing as an intestinal symbiosis factor in a model arthropod host | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,444,100 | June 1, 2021 | June 8, 2026 | WATNICK, PAULA I | reporter.nih.gov |
| Development of MecVax, a Cross Protective Subunit Vaccine for ETEC | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,440,502 | June 1, 2023 | May 31, 2028 | ZHANG, WEIPING | reporter.nih.gov |
| Improving radiolabeled imaging and targeting of HER2 positive EG cancers using lovastatin | NIH | National Cancer Institute | 2021 to 2025 | $3,432,890 | December 1, 2020 | November 30, 2026 | LEWIS, JASON S. | reporter.nih.gov |
| Clinical Research on Nonalcoholic Fatty Liver Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,430,513 | September 15, 2002 | June 30, 2027 | LOOMBA, ROHIT | reporter.nih.gov |
| Chemical tools for developmental biology | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,426,216 | April 1, 2018 | June 30, 2028 | CHEN, JAMES K | reporter.nih.gov |
| Training in Pediatric Gastroenterology, Hepatology, and Nutrition | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,415,797 | December 1, 1983 | April 30, 2029 | SNAPPER, SCOTT B | reporter.nih.gov |
| Optimizing Lung Cancer Screening in Cancer Survivors | NIH | National Cancer Institute | 2021 to 2025 | $3,415,788 | July 15, 2021 | June 30, 2027 | WISNIVESKY, JUAN P | reporter.nih.gov |
| Human Genetic determinants of HBV recovery | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,412,348 | September 30, 1999 | December 31, 2026 | THOMAS, DAVID L | reporter.nih.gov |
| Combating Related Epidemics in HCV through Simplified Testing and Treatment (CREST) | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,411,692 | September 24, 2025 | August 31, 2030 | NAGGIE, SUSANNA | reporter.nih.gov |
| Characterization of Mucosal Lymphocytes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,410,819 | September 30, 1992 | June 30, 2029 | BLUMBERG, RICHARD S | reporter.nih.gov |
| Microbiota-derived metabolites and the regulation of host immunity and inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,409,847 | June 14, 2022 | May 31, 2027 | ARTIS, DAVID | reporter.nih.gov |
| Regulation of TLR signaling, Inflammation and Antigen Presentation by VPS33B | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,409,595 | July 1, 2021 | June 30, 2026 | PASARE, CHANDRASHEKHAR | reporter.nih.gov |
| Uncovering the parasite and host determinants of Plasmodium vivax hypnozoite formation and development using single cell sequencing and human liver-chimeric mice | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,399,010 | February 7, 2022 | January 31, 2027 | VAUGHAN, ASHLEY M | reporter.nih.gov |
| Characterizing Vancomycin-Resistant C. difficile Strains at Two Geographically Distinct Locations | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,395,135 | April 1, 2021 | March 31, 2027 | DARKOH, CHARLES | reporter.nih.gov |
| Remediating fibrosis for salivary gland regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,392,837 | April 1, 2019 | March 31, 2029 | LARSEN, MELINDA | reporter.nih.gov |
| Biology and Function of Exosomes in Cancer | NIH | National Cancer Institute | 2022 to 2025 | $3,385,880 | September 1, 2022 | August 31, 2029 | KALLURI, RAGHU | reporter.nih.gov |
| Evaluation of a community-based education, navigation, and support (CENS) intervention to reduce opioid-related harms among military veterans | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,379,762 | September 30, 2021 | July 31, 2027 | BENNETT, ALEXANDER S | reporter.nih.gov |
| Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,375,729 | September 17, 2021 | August 31, 2027 | DRESKIN, STEPHEN C | reporter.nih.gov |
| Defining the impact of type 1 cytokine signaling on STAT-mediated epithelial reprogramming and barrier dysfunction in eosinophilic esophagitis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,375,359 | July 9, 2025 | June 30, 2029 | RUFFNER, MELANIE A | reporter.nih.gov |
| Commensal control of C. difficile virulence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,372,908 | February 1, 2021 | January 31, 2027 | BRY, LYNN | reporter.nih.gov |
| Integration of genomics and transcriptomics to investigate biological pathways in very early onset IBD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,353,628 | July 1, 2021 | April 30, 2027 | KELSEN, JUDITH RACHEL | reporter.nih.gov |
| AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS | NIH | National Cancer Institute | 2021 to 2025 | $3,349,717 | July 1, 2021 | June 30, 2027 | GUCCIONE, ERNESTO | reporter.nih.gov |
| Promoting remote and secondary risk prevention services in rural settings | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,349,340 | September 30, 2022 | July 31, 2027 | PHO, MAI TUYET | reporter.nih.gov |
| Developing and Testing a Digital Toolkit to Improve Colorectal Cancer Screening Rates in Federally Qualified Health Centers | NIH | National Cancer Institute | 2021 to 2025 | $3,348,072 | April 1, 2021 | March 31, 2027 | MILLER, SARAH J | reporter.nih.gov |
| Gamma delta T cells promote inflammation in aviremic HIV infection and normal aging | NIH | National Institute on Aging | 2021 to 2024 | $3,347,408 | August 15, 2020 | May 31, 2026 | SNYDER-CAPPIONE, JENNIFER E | reporter.nih.gov |
| Targeting Clostridioides difficile with microbiome-sparing, resistant-proof anti-toxins | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,343,705 | April 1, 2021 | March 31, 2026 | SCHRAMM, VERN L. | reporter.nih.gov |
| The PAS Sensor Family and Human Health | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $3,342,660 | September 15, 2017 | May 31, 2026 | BRADFIELD, CHRISTOPHER A | reporter.nih.gov |
| Role of ABCG1, ABCG5 and ABCG8 in Sterol Metabolism | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,341,148 | February 1, 2003 | November 30, 2025 | HOBBS, HELEN HASKELL | reporter.nih.gov |
| Periodontitis Role in Inflammatory Bowel Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,340,009 | September 1, 2025 | August 31, 2029 | THUMBIGERE-MATH, VIVEK | reporter.nih.gov |
| Liquid biopsy and radiomics for liver cancer surveillance | NIH | National Cancer Institute | 2023 to 2025 | $3,338,250 | September 19, 2023 | August 31, 2028 | TAOULI, BACHIR | reporter.nih.gov |
| Immunologic correlates of functional cure of HBV with immune checkpoint blockade | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,338,136 | May 22, 2020 | April 30, 2026 | LAUER, GEORG MICHAEL | reporter.nih.gov |
| Why do Down Syndrome patients have high risk of Hirschsprung disease? | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,330,453 | September 15, 2022 | July 31, 2027 | CHAKRAVARTI, ARAVINDA | reporter.nih.gov |
| Support for Registration Enabling Phase 3 Clinical Trial for Nanotechnology-Based Treatment of Carcinoma in Situ of the Oral Cavity (Stage 0 Oral Cancer) | NIH | National Cancer Institute | 2024 to 2025 | $3,329,707 | June 14, 2024 | May 31, 2027 | GOLDBERG, MANIJEH N | reporter.nih.gov |
| Smarter CRC Supplement for ACCSIS Patient Navigation | NIH | National Cancer Institute | 2021 to 2023 | $3,328,541 | September 23, 2019 | August 31, 2025 | DAVIS, MELINDA MARIE | reporter.nih.gov |
| Cancer Immune-Interception for Lynch Syndrome | NIH | National Cancer Institute | 2021 to 2025 | $3,326,163 | September 21, 2021 | August 31, 2026 | VILAR SANCHEZ, EDUARDO | reporter.nih.gov |
| Real-time MRI-guided adaptive radiotherapy of unresectable pancreatic cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,323,920 | August 13, 2021 | July 31, 2026 | OTAZO, RICARDO | reporter.nih.gov |
| Predictive informatics monitoring in the Neonatal Intensive Care Unit | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,311,236 | July 10, 2014 | April 30, 2027 | FAIRCHILD, KAREN D | reporter.nih.gov |
| "A microbiome-dependent bile acid metabolite improves type 2 diabetes." | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,304,418 | January 8, 2021 | December 31, 2026 | SHEU, ERIC GARLAND | reporter.nih.gov |
| Epigenetic study of oral HPV infection-associated oral cancer in people living with HIV in Nigeria | NIH | National Cancer Institute | 2022 to 2025 | $3,301,620 | September 16, 2022 | August 31, 2027 | HOU, LIFANG | reporter.nih.gov |
| The Influence Of Gut Microbiota Stability In Inflammatory Bowel Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,299,380 | March 4, 2019 | February 28, 2027 | FAITH, JEREMIAH JAMES | reporter.nih.gov |
| A geospatial analysis of hotspots and targeted injection settings pilot intervention for HIV prevention among people who inject drugs in Baltimore, Maryland | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,292,995 | July 1, 2020 | May 31, 2027 | LATKIN, CARL A | reporter.nih.gov |
| Impact of HIV, oral microbiome and mycobiome on oral HPV persistence | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $3,289,768 | September 1, 2022 | August 31, 2027 | BURK, ROBERT D | reporter.nih.gov |
| Fibroblast orchestration of the immune response in pancreatic cancer | NIH | National Cancer Institute | 2022 to 2025 | $3,286,816 | September 19, 2022 | August 31, 2027 | PASCA DI MAGLIANO, MARINA | reporter.nih.gov |
| A smartphone-enabled point-of-care HCV Ag diagnostic using catalytic nanoparticles and AI-enhanced image processing | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $3,284,055 | September 9, 2022 | June 30, 2027 | SHAFIEE, HADI | reporter.nih.gov |
| Prevention of Pediatric NAFLD in Hispanic Children | NIH | National Institute of Nursing Research | 2021 to 2025 | $3,279,874 | April 5, 2021 | January 31, 2026 | WELSH, JEAN A. | reporter.nih.gov |
| Leveraging Hyperpolarized MRI for Precision Oncology Approaches in Head and Neck Cancer | NIH | National Cancer Institute | 2022 to 2025 | $3,278,152 | September 1, 2022 | August 31, 2028 | LAI, STEPHEN Y | reporter.nih.gov |
| Diet transformation by the microbiome and its impact on bacterial infection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,277,659 | August 16, 2022 | May 31, 2027 | GOODMAN, ANDREW L | reporter.nih.gov |
| Prospective evaluation of outcomes in cirrhosis of different etiologies: impact of HIV infection and simvastatin therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,276,651 | September 23, 2021 | July 31, 2027 | DASARATHY, SRINIVASAN | reporter.nih.gov |
| Stable therapy in Pompe disease through genome editing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,274,213 | August 1, 2021 | July 31, 2026 | KOEBERL, DWIGHT D | reporter.nih.gov |
| The Role of Secondary Bile Acids in Gastro-Esophageal Neoplasia | NIH | National Cancer Institute | 2022 to 2025 | $3,273,998 | September 1, 2022 | August 31, 2027 | ABRAMS, JULIAN | reporter.nih.gov |
| IL-27R signaling as a negative regulator of innate and adaptive anti-cancer immunity in hepatocellular carcinoma | NIH | National Cancer Institute | 2022 to 2025 | $3,273,154 | August 1, 2022 | July 31, 2027 | KOLTSOVA, EKATERINA | reporter.nih.gov |
| Functional outcomes of inflammatory bowel disease associated variants | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,272,687 | September 18, 2013 | May 31, 2028 | ABRAHAM, CLARA | reporter.nih.gov |
| Genomic Epidemiology of Campylobacter to Improve Disease Control in Low and Middle Income Countries | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,270,801 | March 15, 2021 | February 28, 2027 | KOSEK, MARGARET N | reporter.nih.gov |
| Advanced Development of a Combined Shigella-ETEC Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,267,570 | June 9, 2023 | May 31, 2028 | BARRY, EILEEN M. | reporter.nih.gov |
| Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,264,543 | April 1, 2021 | March 31, 2027 | SCHMIDT, CHRISTIAN MAXIMILLIAN | reporter.nih.gov |
| Longitudinal Study of Early NAFLD Progression and the Gut Microbiome in Asian Americans, Native Hawaiians and Whites | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $3,263,901 | September 26, 2022 | June 30, 2027 | LIM, UNHEE | reporter.nih.gov |
| Aspiration in Acute Respiratory Failure Survivors | NIH | National Institute of Nursing Research | 2021 to 2025 | $3,262,196 | August 23, 2021 | May 31, 2027 | MOSS, MARC | reporter.nih.gov |
| Decoding mutualistic microbiota-B cell interactions in the HIV-1-infected gut: impact on immunological non-responders | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,259,183 | May 7, 2020 | April 30, 2026 | MEHANDRU, SAURABH | reporter.nih.gov |
| Liver Cirrhosis Network: Longitudinal and Clinical Trial Studies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,258,965 | September 6, 2021 | July 31, 2027 | KHALILI, MANDANA | reporter.nih.gov |
| Identification of enteric Juvenile Protective Factors and their role in stimulating neurogenesis in the adult and ageing Enteric Nervous System | NIH | National Institute on Aging | 2021 to 2025 | $3,254,354 | January 15, 2021 | December 31, 2026 | GOFF, LOYAL ANDREW | reporter.nih.gov |
| Lead optimization of Hepatitis B Virus ribonuclease H inhibitors | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,253,243 | December 1, 2020 | November 30, 2026 | TAVIS, JOHN E | reporter.nih.gov |
| Genetic and Molecular Dissection of Wnt Pathway Activation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,246,880 | June 1, 2020 | July 31, 2030 | AHMED, YASMATH | reporter.nih.gov |
| Implementation of telemedicine and social network driven HIV service uptake for comprehensive HIV service integration in rural syringe service programs | NIH | National Institute on Drug Abuse | 2023 to 2025 | $3,234,132 | August 1, 2023 | May 31, 2028 | FALADE-NWULIA, OLUWASEUN | reporter.nih.gov |
| Role of Neutrophils in the Pathogenesis of Cholangiopathies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,233,421 | September 1, 2025 | August 31, 2029 | STRAZZABOSCO, MARIO | reporter.nih.gov |
| Clinical Validation Center for Early Detection of Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2024 | $3,231,816 | May 4, 2016 | August 31, 2027 | MAITRA, ANIRBAN | reporter.nih.gov |
| Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasis | NIH | National Cancer Institute | 2021 to 2025 | $3,231,041 | August 9, 2021 | July 31, 2026 | SMALLEY, KEIRAN | reporter.nih.gov |
| Glycomic Modulation of Gut Microbiome During HIV Infection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,228,597 | December 24, 2019 | November 30, 2025 | ABDEL MOHSEN, MOHAMED | reporter.nih.gov |
| Imaging Modulation of Immune Phenotype | NIH | National Cancer Institute | 2021 to 2025 | $3,227,270 | February 1, 2021 | January 31, 2027 | FERRARA, KATHERINE W | reporter.nih.gov |
| Defining the β-catenin/CBP-catenin/CBP axis in head and neck cancer | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,223,525 | December 7, 2020 | November 30, 2026 | KUKURUZINSKA, MARIA A. | reporter.nih.gov |
| A neurocomputational assay of gastrointestinal interoception in anorexia nervosa | NIH | National Institute of Mental Health | 2021 to 2025 | $3,222,559 | September 1, 2021 | June 30, 2027 | KHALSA, SAHIB S. | reporter.nih.gov |
| Decoding the clinical impact of the recent evolution of metronidazole resistance on Clostridium difficile infection. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,220,673 | August 20, 2018 | January 31, 2028 | HURDLE, JULIAN G | reporter.nih.gov |
| Examine Individual and Clinical Factors Affecting Liver Disease Management | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $3,219,854 | September 15, 2022 | May 31, 2027 | MA, GRACE X. | reporter.nih.gov |
| Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,218,917 | August 15, 2015 | June 30, 2026 | JENQ, ROBERT | reporter.nih.gov |
| Addressing Chemoresistance in Pancreatic and Ovarian Cancers: Photodynamic Priming and Repurposing of Tetracyclines using Targeted Photo-Activable Multi-Inhibitor Liposome | NIH | National Cancer Institute | 2021 to 2025 | $3,218,280 | April 1, 2021 | March 31, 2027 | HUANG, HUANG CHIAO | reporter.nih.gov |
| Self-Management to Optimize Survivorship Care and Outcomes in Lung and Colorectal Cancer | NIH | National Cancer Institute | 2021 to 2024 | $3,217,584 | April 2, 2020 | March 31, 2026 | SUN, VIRGINIA CHIH-YI | reporter.nih.gov |
| Epidemiologic identification and mechanistic investigation of early life environmental risk factors for eosinophilic esophagitis | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,217,424 | April 1, 2021 | January 31, 2027 | DELLON, EVAN SAMUEL | reporter.nih.gov |
| Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,216,546 | March 1, 2021 | February 28, 2027 | WEISMAN, GARY ANDREW | reporter.nih.gov |
| Integrated Model for the Prevention of Anal Cancer using screen and Treat for HSIL (IMPACT) | NIH | National Cancer Institute | 2022 to 2025 | $3,210,795 | September 15, 2022 | August 31, 2027 | NOWAK, REBECCA G. | reporter.nih.gov |
| Active Disposable Cap for Endoscope Tip Stabilization and Complete Visualization and Dissection of Serrated Sessile Polyps | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $3,206,138 | August 7, 2018 | August 31, 2025 | MULVIHILL, MAUREEN L. | reporter.nih.gov |
| Sjögren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen) | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $3,205,764 | June 1, 2020 | November 30, 2025 | SHIBOSKI, CAROLINE HELENE | reporter.nih.gov |
| B cell clonal selection in gut-associated germinal centers | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,203,164 | September 17, 2020 | August 31, 2025 | VICTORA, GABRIEL D | reporter.nih.gov |
| The impact of non-dysentery Shigella-associated diarrhea in children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,197,662 | March 9, 2021 | February 28, 2027 | CHAKRABORTY, SUBHRA | reporter.nih.gov |
| Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma | NIH | National Cancer Institute | 2021 to 2025 | $3,197,232 | January 18, 2021 | December 31, 2026 | ZHU, YAZHEN | reporter.nih.gov |
| Roles and regulation of tissue resident CD8 T cells during a persistent viral infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,194,992 | July 16, 2025 | June 30, 2029 | ZUNIGA, ELINA I | reporter.nih.gov |
| Immunomodulation in AAV gene therapy | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,192,404 | August 21, 2025 | July 31, 2029 | ASOKAN, ARAVIND | reporter.nih.gov |
| Host Responses to the Pore-Forming Toxin Listeriolysin O | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,191,205 | April 1, 2021 | March 31, 2027 | SEVEAU, STEPHANIE M M | reporter.nih.gov |
| Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes | NIH | National Cancer Institute | 2021 to 2025 | $3,190,411 | April 5, 2021 | March 31, 2027 | SPIEGEL, BRENNAN | reporter.nih.gov |
| Neutralizing antibody responses during natural control of acute hepatitis B with and without HIV-1 coinfection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,186,484 | August 1, 2022 | July 31, 2027 | BAILEY, JUSTIN RICHARD | reporter.nih.gov |
| Long-Term Islet Function and Impact after Total Pancreatectomy with Islet Autotransplant (LIFT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,185,530 | January 15, 2021 | December 31, 2026 | BELLIN, MELENA D. | reporter.nih.gov |
| Collaborative Integration of HCV Molecular Virology and Mathematical Modeling | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,185,361 | August 1, 2010 | May 31, 2027 | UPRICHARD, SUSAN L. | reporter.nih.gov |
| Alanyl-glutamine supplementation of standard treatment for C. difficile infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,184,912 | July 13, 2020 | June 30, 2026 | WARREN, CIRLE ALCANTARA | reporter.nih.gov |
| Intestinal proteases in alcohol-associated liver disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $3,182,397 | September 20, 2025 | August 31, 2029 | SCHNABL, BERND G. | reporter.nih.gov |
| Investigation of Yop activities in M cells during murine infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,178,626 | August 26, 2025 | July 31, 2029 | MECSAS, JOAN C | reporter.nih.gov |
| Novel macrophage mediated signals regulate the immunoregulatory environment of the neonatal liver | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,176,680 | September 15, 2025 | September 14, 2029 | NIJAGAL, AMAR | reporter.nih.gov |
| Simultaneous MRI/US for real-time liver ablation guidance and confirmation | NIH | National Cancer Institute | 2022 to 2025 | $3,174,892 | August 15, 2022 | July 31, 2027 | HOLMES, JAMES H | reporter.nih.gov |
| Peripherally-restricted non-addictive cannabinoids for cancer pain treatment | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $3,174,343 | August 1, 2023 | July 31, 2025 | SPIGELMAN, IGOR | reporter.nih.gov |
| Drug eluting injectable biomaterials for next generation chemoembolization | NIH | National Cancer Institute | 2021 to 2025 | $3,173,416 | May 1, 2021 | April 30, 2027 | OKLU, RAHMI | reporter.nih.gov |
| Fluorescence Lifetime Imaging/Spectroscopy System For Robotic Cancer Surgery Guidance | NIH | National Cancer Institute | 2021 to 2025 | $3,170,664 | September 12, 2014 | April 30, 2027 | MARCU, LAURA | reporter.nih.gov |
| Autologous BM-MSCs and Islet Co-transplantation to Enhance Islet Survival and Function in TP-IAT Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,169,762 | August 24, 2021 | May 31, 2027 | WANG, HONGJUN | reporter.nih.gov |
| CTRP and Metabolic Control | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,168,077 | July 15, 2010 | June 30, 2028 | WONG, GUANG WILLIAM | reporter.nih.gov |
| A Patient-Centric Approach to Advance Functional Precision Oncology | NIH | National Cancer Institute | 2023 to 2025 | $3,167,628 | September 22, 2023 | August 31, 2028 | KEMP, CHRISTOPHER J | reporter.nih.gov |
| Development of peptide nucleic acid antibiotics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,164,488 | February 10, 2021 | January 31, 2025 | ARYA, DEV PRIYA | reporter.nih.gov |
| Role of Intestinal Parasites on Regulating Immune Responses to Gut Antigens | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,164,043 | June 22, 2022 | May 31, 2027 | EDELSON, BRIAN TODD | reporter.nih.gov |
| Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link | NIH | National Cancer Institute | 2021 to 2025 | $3,159,289 | September 23, 2021 | August 31, 2026 | ULRICH, CORNELIA M | reporter.nih.gov |
| Low Cost Tethered Capsule Endoscope with High-Resolution Digital Chromoscopy for Barrett's Screening | NIH | National Cancer Institute | 2021 to 2025 | $3,157,352 | July 1, 2021 | June 30, 2027 | RICHARDS-KORTUM, REBECCA R. | reporter.nih.gov |
| Launching HBV with RNA to assess antiviral resistance and explore fundamental aspects of virus-host biology | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,156,556 | February 10, 2020 | April 30, 2030 | RICE, CHARLES M | reporter.nih.gov |
| Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity | NIH | National Cancer Institute | 2023 to 2025 | $3,154,814 | September 19, 2023 | August 31, 2028 | BROWN, BRIAN D | reporter.nih.gov |
| Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,153,883 | September 24, 2018 | October 31, 2028 | HEYSELL, SCOTT K | reporter.nih.gov |
| Extracellular vesicle cargo and risk of NAFLD and NASH in U.S. youth | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,153,279 | April 15, 2022 | February 28, 2027 | DISTEFANO, JOHANNA K | reporter.nih.gov |
| Impacting the oral HPV continuum: prevention, screening, and early detection | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $3,152,738 | September 23, 2016 | June 30, 2025 | D'SOUZA, GYPSYAMBER | reporter.nih.gov |
| Impact of harm reduction care in HIV clinical settings on stigma and health outcomes for PLWH who use drugs | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,152,106 | September 30, 2021 | June 30, 2027 | HAWK, MARY ELIZABETH | reporter.nih.gov |
| Mechanistic understanding of the lifecycle of a circulating hybrid cell | NIH | National Cancer Institute | 2021 to 2025 | $3,151,928 | June 1, 2021 | May 31, 2027 | WONG, MELISSA H. | reporter.nih.gov |
| Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk | NIH | National Cancer Institute | 2021 to 2025 | $3,149,705 | January 15, 2021 | December 31, 2026 | FITZGIBBON, MARIAN L. | reporter.nih.gov |
| Dendritic cell intrinsic UPR is critical for pathogen specific Th17 responses | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,147,392 | September 1, 2025 | August 31, 2029 | PASARE, CHANDRASHEKHAR | reporter.nih.gov |
| Vibrio cholerae antinitrosative stress defenses and gut microbiome interaction | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,145,639 | September 23, 2020 | August 31, 2025 | ZHU, JUN | reporter.nih.gov |
| Microbiome, Environment, and Parkinsons disease (MEP) PESTICIDE EXPOSURES AND THE GUT MICROBIOME IN PARKINSONS DISEASE | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,143,396 | August 15, 2020 | June 30, 2026 | RITZ, BEATE R. | reporter.nih.gov |
| New Generation of Mitochondrial Uncouplers for the Treatment of Metabolic DIsorders | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $3,142,274 | September 20, 2021 | June 30, 2026 | VU, SIMON | reporter.nih.gov |
| Allergen Loaded Nanoparticles for Food Allergy Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,140,831 | September 16, 2020 | August 31, 2025 | SHEA, LONNIE D | reporter.nih.gov |
| Coordinating Center for the Program on the Origins of Gastroesophageal Cancers | NIH | National Cancer Institute | 2022 to 2025 | $3,140,717 | September 6, 2022 | August 31, 2027 | HUR, CHIN | reporter.nih.gov |
| Coordinated studies in monkeys and humans to assess the immunological impact of rectal Chlamydia trachomatis infection on protection against genital infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,139,154 | April 1, 2023 | March 31, 2028 | VOJTECH, LUCIA N | reporter.nih.gov |
| Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,135,340 | September 21, 2021 | August 31, 2026 | ZARRINPAR, AMIR | reporter.nih.gov |
| Shigella Conjugate Vaccine (SCV4) Development, Characterization, and Pre-clinical Evaluation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,134,727 | June 23, 2023 | May 31, 2028 | RYAN, EDWARD T. | reporter.nih.gov |
| Oral microbiome and periodontal diseases in oral HPV infection among people living with HIV | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $3,134,374 | August 11, 2022 | July 31, 2027 | XIAO, CANHUA | reporter.nih.gov |
| The Ecology of Barrett's Esophagus | NIH | National Cancer Institute | 2025 | $3,130,492 | August 22, 2025 | July 31, 2029 | MALEY, CARLO | reporter.nih.gov |
| Molecular mechanisms driving the coevolution of clinical isolates of phages and epidemic Vibrio cholerae | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,128,015 | June 1, 2020 | May 31, 2030 | SEED, KIMBERLEY DIANE | reporter.nih.gov |
| Modeling intestinal dysfunction in HIV infection with organoid technology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,127,465 | January 10, 2020 | December 31, 2025 | OTT, MELANIE MARIA | reporter.nih.gov |
| Microbiota, Metabolites, and Colon Neoplasia | NIH | National Cancer Institute | 2021 to 2025 | $3,124,761 | May 1, 2021 | April 30, 2027 | ROSENBERG, DANIEL WILLIAM | reporter.nih.gov |
| Structural and functional studies of colibactin | NIH | National Cancer Institute | 2021 to 2025 | $3,124,458 | December 11, 2017 | February 29, 2028 | HERZON, SETH B. | reporter.nih.gov |
| Intestinal microbiota-mediated rotavirus vaccine failure | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,123,686 | September 19, 2022 | July 31, 2027 | GEWIRTZ, ANDREW T | reporter.nih.gov |
| Innate lymphoid cell regulation of the host-microbiota interactions in cancer | NIH | National Cancer Institute | 2022 to 2025 | $3,122,275 | September 20, 2022 | August 31, 2027 | SONNENBERG, GREGORY F | reporter.nih.gov |
| Serial immunotherapy combination to modulate the tumor environment in patients with metastatic gastroesophageal cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,119,133 | January 1, 2021 | December 31, 2026 | YOON, HARRY H | reporter.nih.gov |
| SPHERE (Survivorship Plan Health Record) Implementation Trial | NIH | National Cancer Institute | 2021 to 2025 | $3,117,615 | June 1, 2021 | May 31, 2027 | HAGGSTROM, DAVID ANDREW | reporter.nih.gov |
| Molecular and structural characterization of broadly neutralizing anti-HCV antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,115,747 | February 15, 2023 | January 31, 2028 | BAILEY, JUSTIN RICHARD | reporter.nih.gov |
| Microbiota-immune interactions that promote intestinal homeostasis | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $3,111,145 | June 15, 2021 | May 31, 2026 | ROUND, JUNE LOUISE | reporter.nih.gov |
| The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma | NIH | National Cancer Institute | 2021 to 2025 | $3,108,327 | January 1, 2021 | December 31, 2026 | ABRAMS, JULIAN | reporter.nih.gov |
| Autonomous Grippers in the Gastrointestinal Tract | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $3,105,853 | September 26, 2014 | June 30, 2026 | SELARU, FLORIN | reporter.nih.gov |
| Mechanisms of the Development and Maintenance of Salmonella Gallbladder Carriage | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,105,141 | June 1, 2015 | April 30, 2027 | GUNN, JOHN S | reporter.nih.gov |
| Epigenetics of human Hepatic Stellate Cells (HSCs) in NASH | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,103,795 | May 15, 2014 | August 31, 2027 | KISSELEVA, TATIANA | reporter.nih.gov |
| Role of Lipogenic Pathways in Intestinal Remodeling after Gastric Bypass Surgery | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,103,125 | September 3, 2025 | September 2, 2029 | STEFATER-RICHARDS, MARGARET | reporter.nih.gov |
| Modeling diabetes using an integrated plate system | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $3,092,998 | September 20, 2018 | July 31, 2024 | WELLS, JAMES M | reporter.nih.gov |
| Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,092,811 | February 15, 2021 | January 31, 2026 | DONAHUE, TIMOTHY R | reporter.nih.gov |
| Mechanisms Regulating Neurotensin Secretion and Function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,092,161 | February 1, 2017 | June 30, 2026 | EVERS, BERNARD MARK | reporter.nih.gov |
| Impact of metabolic programing of T cells from the GI tract and related tissues on HIV reservoir seeding, maintenance and reactivation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,091,749 | September 30, 2021 | July 31, 2027 | APETREI, CRISTIAN | reporter.nih.gov |
| Characterizing the Risk of Chemotherapy Side Effects Based on Epigenetic Age and Modification by Resistance Training Intervention | NIH | National Cancer Institute | 2021 to 2025 | $3,091,560 | September 8, 2021 | August 31, 2027 | BINDER, ALEXANDRA MARGARET LYNN | reporter.nih.gov |
| Immune determinants of progression from Oral Epithelial Dysplasia to Oral Squamous Cell Carcinoma by precision multiplexed imaging | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $3,081,662 | June 15, 2022 | March 31, 2027 | SPITZER, MATTHEW | reporter.nih.gov |
| Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,080,631 | February 3, 2021 | January 31, 2027 | LOKSHIN, ANNA E. | reporter.nih.gov |
| TRPV1 nociceptors in oral carcinogenesis and pain | NIH | National Cancer Institute | 2021 to 2025 | $3,070,266 | March 1, 2021 | February 28, 2027 | ALBERTSON, DONNA G | reporter.nih.gov |
| Optimizing a patient-specific regenerative larynx implant for restoration of voice | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $3,070,095 | September 1, 2021 | August 31, 2027 | LOTT, DAVID G | reporter.nih.gov |
| Small GTP Binding Proteins in Gastrointestinal Mucosa | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,070,009 | August 1, 1997 | July 31, 2027 | GOLDENRING, JAMES RICHARD | reporter.nih.gov |
| Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen | NIH | National Cancer Institute | 2021 to 2025 | $3,068,738 | September 13, 2021 | August 31, 2027 | KHAZAIE, KHASHAYARSHA | reporter.nih.gov |
| Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,067,940 | April 5, 2017 | March 31, 2027 | BROUWER, KIM L.R. | reporter.nih.gov |
| Translational studies of hookworm infection in Ghana | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,065,354 | February 22, 2022 | January 31, 2027 | CAPPELLO, MICHAEL | reporter.nih.gov |
| Anti-norovirus protease inhibitors for immunocompromised patients | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,063,131 | August 11, 2023 | July 31, 2027 | SCHINAZI, RAYMOND FELIX | reporter.nih.gov |
| LIVOPT -- LIVer cirrhosis - Optimizing Prediction of Patient OuTcomes | NIH | National Institute on Aging | 2021 to 2025 | $3,057,044 | September 30, 2021 | May 31, 2027 | LADNER, DANIELA P | reporter.nih.gov |
| RNA modifications in apolipoprotein regulation by environmental exposures | NIH | National Institute of Environmental Health Sciences | 2025 | $3,051,769 | September 11, 2025 | August 31, 2029 | KLINGE, CAROLYN M. | reporter.nih.gov |
| Bile acid composition and insulin sensitivity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,050,866 | September 15, 2017 | August 31, 2027 | HAEUSLER, REBECCA ANNE | reporter.nih.gov |
| Mechanism of action for the epithelial-specific ER stress sensor IRE1β in regulating intestinal homeostasis and host defense | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,050,147 | September 1, 1993 | March 31, 2026 | LENCER, WAYNE I | reporter.nih.gov |
| The Impact of HCV Treatment in HIV/HCV coinfected and HCV monoinfected Incarcerated Persons on HCV Elimination | NIH | National Institute on Drug Abuse | 2021 to 2024 | $3,045,888 | September 30, 2020 | August 31, 2025 | IRVIN, RISHA | reporter.nih.gov |
| Influence of maternal virome and HIV status on infant gut virome, growth and immunity | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $3,044,222 | September 21, 2020 | August 31, 2025 | JASPAN, HEATHER BERYL | reporter.nih.gov |
| Integrative single cell analyses of inflammation-derived circulating hybrid cells to identify aggressive disease | NIH | National Cancer Institute | 2021 to 2025 | $3,044,035 | April 1, 2021 | March 31, 2027 | WONG, MELISSA H. | reporter.nih.gov |
| Therapeutic Targeting Mitochondrial C1 Metabolism | NIH | National Cancer Institute | 2021 to 2025 | $3,043,890 | January 1, 2021 | December 31, 2026 | MATHERLY, LARRY H | reporter.nih.gov |
| Defecation mechanisms and subtyping of constipation patients with Fecobionics | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,042,512 | June 15, 2021 | May 31, 2027 | GREGERSEN, HANS | reporter.nih.gov |
| GMP MANUFACTURE OF CLINICAL GRADE THERAPEUTIC VACCINE FOR THE TREATMENT OF PATIENTS WITH CHRONIC HBV | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,034,670 | June 5, 2018 | March 31, 2025 | NAKAAR, VALERIAN | reporter.nih.gov |
| TASK D10: A PHASE 1 TRIAL TO EVALUATE A TREATMENT FOR CLOSTRIDIOIDES DIFFICILE | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,033,881 | January 14, 2022 | January 13, 2032 | SPITZ, ROBERT | reporter.nih.gov |
| Lactoferrin and lysozyme to promote nutritional, clinical, and enteric recovery: A factorial placebo-controlled randomized trial among children with diarrhea and malnutrition | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,033,175 | January 1, 2021 | November 30, 2025 | PAVLINAC, PATRICIA | reporter.nih.gov |
| Dissecting the pathogenesis and outcomes of PSC using multi-omics by studying the exposome and genome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $3,027,125 | September 1, 2018 | July 31, 2025 | LAZARIDIS, KONSTANTINOS N | reporter.nih.gov |
| Mitigation of Radiation Induced Gastrointestinal Syndrome. | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,026,290 | August 1, 2023 | July 31, 2026 | NORRIS, ANDREW JOHN | reporter.nih.gov |
| Study the Treg-IL-27 axis in immune regulation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,022,197 | July 8, 2025 | June 30, 2029 | LU, LI-FAN | reporter.nih.gov |
| Mechanistic basis of bacteriophages for the decolonization of vancomycin resistant enterococci in the intestine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,022,123 | September 14, 2018 | July 31, 2028 | DUERKOP, BRECK A | reporter.nih.gov |
| Elucidation of Pathogenic Mechanisms underlying Norovirus Diarrhea | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,019,785 | June 1, 2021 | May 31, 2026 | KARST, STEPHANIE M | reporter.nih.gov |
| The Role of Type VI Secretion in Cholera Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,019,658 | January 18, 2019 | December 31, 2025 | PUKATZKI, STEFAN | reporter.nih.gov |
| A Randomized Trial to Test the Efficacy of a Partner Navigation Intervention for HCV Treatment among Young Adult People who Inject Drugs | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,017,588 | June 1, 2022 | March 31, 2027 | MORRIS, MEGHAN D | reporter.nih.gov |
| Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,016,918 | September 30, 2024 | September 29, 2025 | SUMNER, LOUISE | reporter.nih.gov |
| CARES-REACH (Colorectal Cancer Awareness, Research, Education and Screening-Rural Expansion, Access and Capacity for Health) | NIH | National Cancer Institute | 2021 to 2024 | $3,016,341 | April 1, 2020 | March 31, 2026 | GWEDE, CLEMENT K. | reporter.nih.gov |
| HAWAII CLINICAL RESEARCH NETWORK FOR HEALTH EQUITY | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2023 | $3,015,250 | September 24, 2022 | June 30, 2024 | SHIKUMA, CECILIA M. | reporter.nih.gov |
| Role of the p53 P47S mutation in influencing prevalence and immune response to H. pylori | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,013,399 | January 20, 2021 | December 31, 2026 | CLAIBORNE, DANIEL THOMAS | reporter.nih.gov |
| Uncovering the rules of gut microbiome strain transmission | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,013,179 | January 20, 2020 | December 31, 2028 | FAITH, JEREMIAH JAMES | reporter.nih.gov |
| Dietary Fiber-Microbiome Interactions: Elucidating Mechanisms to Suppress Multi-Drug Resistant Organisms in the Human Gut | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,012,181 | September 10, 2025 | August 31, 2029 | VENTURELLI, OPHELIA | reporter.nih.gov |
| Multi-level Evaluation of Racial/ethnic Disparities in Liver Disease Outcomes | NIH | National Cancer Institute | 2021 to 2025 | $3,010,755 | March 18, 2021 | February 28, 2027 | KANWAL, FASIHA | reporter.nih.gov |
| Non-Clinical Pharmacology of CX-01 | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,007,043 | June 1, 2014 | January 31, 2027 | VID, GALINA | reporter.nih.gov |
| CyberGut: towards personalized human-microbiome metabolic modeling for precision health and nutrition | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,006,256 | July 1, 2022 | April 30, 2027 | GIBBONS, SEAN MICHAEL | reporter.nih.gov |
| Generating Exogenic Organs for Transplantation without the Use of Immunosuppression | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,005,890 | September 21, 2022 | July 31, 2027 | STEER, CLIFFORD JOHN | reporter.nih.gov |
| Harnessing human brain and liver microphysiological systems for testing therapeutics for metastatic melanoma | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $3,003,024 | August 1, 2018 | July 31, 2024 | WIKSWO, JOHN PETER | reporter.nih.gov |
| Mechanisms of T Cell Quiescence and Exhaustion | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,001,713 | March 1, 2019 | February 28, 2029 | SARKAR, SUROJIT | reporter.nih.gov |
| The REASON Score: An Epigenetic And Clinicopathologic Score to Predict Risk of Poor Survival in Early Stage Oral Squamous Cell Carcinoma Patients | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $3,001,101 | August 11, 2022 | May 31, 2027 | VIET, CHI T. | reporter.nih.gov |
| Regulating cell fate and shaping the body plan during morphogenesis and their alteration during oncogenesis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,000,444 | July 1, 2016 | August 31, 2026 | PEIFER, MARK A. | reporter.nih.gov |
| Preclinical development of capsid assembly modulators for the treatment of chronic hepatitis B virus infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,000,000 | May 24, 2021 | April 30, 2025 | COBURN, GLEN ANDREW | reporter.nih.gov |
| Regulation of mitochondrial health in mammalian livers. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,999,512 | September 1, 2025 | August 31, 2029 | MISHRA, PRASHANT | reporter.nih.gov |
| A genetically modified Plasmodium falciparum sporozoite vaccine attenuated at the late-liver stage | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,998,001 | April 21, 2020 | March 31, 2027 | SIM, B. KIM LEE | reporter.nih.gov |
| Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer | NIH | National Cancer Institute | 2022 to 2024 | $2,997,017 | June 3, 2022 | February 28, 2025 | BROWN, JUSTIN C | reporter.nih.gov |
| Development of TP-317 in Ulcerative Colitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,996,955 | September 18, 2017 | February 28, 2027 | PARKINSON, JOHN | reporter.nih.gov |
| DIRECT TO PHASE II SBIR CONCEPT AWARD FOR NOVEL IONTOPHORETIC DRUG DELIVERY DEVICE FOR LOCAL AND EFFECTIVE TREATMENT OF ORAL CANCER | NIH | National Cancer Institute | 2025 | $2,995,581 | September 5, 2025 | September 4, 2027 | HAM, STEPHANIE | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of California Los Angeles | Los Angeles, CA | 102 | $685.7 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 188 | $291.5 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 256 | $260.9 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 173 | $236 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 197 | $235 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 192 | $215.7 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 165 | $215.1 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 217 | $203.6 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 143 | $201.2 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 149 | $199.3 million | 0 | $0 |
| Washington University | Saint Louis, MO | 192 | $193.5 million | 0 | $0 |
| Yale University | New Haven, CT | 153 | $190.2 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 132 | $182.3 million | 0 | $0 |
| Stanford University | Stanford, CA | 153 | $181.2 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 116 | $172.7 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 142 | $169.9 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 109 | $160.4 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 98 | $149.3 million | 0 | $0 |
| Duke University | Durham, NC | 118 | $131.7 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 113 | $128.3 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 94 | $125.9 million | 0 | $0 |
| University of Washington | Seattle, WA | 96 | $125.3 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 123 | $120.2 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 73 | $120 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 66 | $113 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 114 | $112.7 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 67 | $109.9 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 52 | $109.4 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 92 | $103.5 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 62 | $100.3 million | 0 | $0 |
| Emory University | Atlanta, GA | 107 | $95.5 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 94 | $94.2 million | 0 | $0 |
| University of Chicago | Chicago, IL | 78 | $92 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 69 | $90.9 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 61 | $87.3 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 69 | $84.2 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 52 | $82.9 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 70 | $79.7 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 60 | $79.1 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 71 | $78.8 million | 0 | $0 |
| University of Florida | Gainesville, FL | 94 | $75.4 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 62 | $74.8 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 44 | $73.6 million | 0 | $0 |
| Ohio State University | Columbus, OH | 75 | $73.2 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 63 | $71.8 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 36 | $70.6 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 63 | $68.7 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 64 | $65.5 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 71 | $65 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 53 | $64.4 million | 0 | $0 |
| University of Louisville | Louisville, KY | 50 | $64.1 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 59 | $62.6 million | 0 | $0 |
| University of California at Davis | Davis, CA | 70 | $61.8 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 60 | $61.3 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 50 | $59.8 million | 0 | $0 |
| H. Lee Moffitt Cancer CTR & Res Inst | Tampa, FL | 24 | $59.6 million | 0 | $0 |
| Dana-Farber Cancer Inst | Boston, MA | 49 | $51.9 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 54 | $51.1 million | 0 | $0 |
| University of Oklahoma HLTH Sciences CTR | Oklahoma City, OK | 47 | $50.6 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 43 | $49.2 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 47 | $48.9 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 43 | $46.7 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 38 | $45.5 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 23 | $45.1 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 32 | $45 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 36 | $42.9 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 33 | $42.7 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 41 | $42.4 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 29 | $41.8 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 47 | $41 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 41 | $41 million | 0 | $0 |
| Saint Louis University | Saint Louis, MO | 19 | $39.9 million | 0 | $0 |
| New York University | New York, NY | 23 | $38.4 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 29 | $37.3 million | 0 | $0 |
| Cold Spring Harbor Laboratory | Cold Spring Harbor, NY | 15 | $36.7 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 41 | $36.3 million | 0 | $0 |
| University of Illinois at Urbana-Champaign | Urbana, IL | 34 | $35.2 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 25 | $34.3 million | 0 | $0 |
| Rockefeller University | New York, NY | 27 | $34.2 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 32 | $34.2 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 33 | $33.9 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 41 | $32.7 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 33 | $31.4 million | 0 | $0 |
| Salk Institute for Biological Studies | La Jolla, CA | 13 | $30.7 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 31 | $30.4 million | 0 | $0 |
| North Carolina State University | Raleigh, NC | 24 | $30.4 million | 0 | $0 |
| Lurie Children's Hospital of Chicago | Chicago, IL | 17 | $30.3 million | 0 | $0 |
| University of Rochester | Rochester, NY | 32 | $29.9 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 23 | $29.7 million | 0 | $0 |
| Wayne State University | Detroit, MI | 26 | $29.6 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 25 | $28.6 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 22 | $27.7 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 15 | $26.1 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 27 | $26 million | 0 | $0 |
| University of Hawaii | Honolulu, HI | 14 | $25.7 million | 0 | $0 |
| Oklahoma Medical Research Foundation | Oklahoma City, OK | 11 | $24.5 million | 0 | $0 |
| Mayo Clinic Arizona | Scottsdale, AZ | 18 | $24.3 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 20 | $23.6 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 23 | $23.2 million | 0 | $0 |
| Georgetown University | Washington, DC | 33 | $22.9 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 4,231 | $2,378,928,397 | 0 | $0 |
| 2024 | 4,491 | $2,199,454,153 | 0 | $0 |
| 2023 | 4,491 | $2,251,667,091 | 0 | $0 |
| 2022 | 4,458 | $2,201,388,939 | 0 | $0 |
| 2021 | 4,433 | $2,143,559,393 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.